Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.675808630984591e-37,34.59011314655172,2912.881744030817,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS4Y1', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.5787270922809086e-34,0,0,81
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,7.279913848462736e-13,4.824759100642399,134.84471787468658,"['COX7B', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'UQCRC1', 'NDUFS3', 'NDUFS2', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.1475745852965073e-10,0,0,57
3,Oxidative phosphorylation WP623,1.651597598678571e-08,5.054535780792764,90.571911671812,"['NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO', 'NDUFS2']",3.248141944067856e-06,0,0,34
4,Glycolysis and Gluconeogenesis WP534,4.5373995201894963e-07,6.934433837178467,101.28254873985621,"['TPI1', 'MDH1', 'GOT1', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A1', 'SLC2A3', 'ENO1', 'ENO2', 'GCK', 'LDHB', 'LDHA', 'PFKL', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'PFKM', 'GAPDH']",6.692664292279507e-05,0,0,22
5,Nonalcoholic fatty liver disease WP4396,9.734538809257414e-06,2.2008176195855995,25.397061839737223,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'COX4I1', 'COX6A1', 'COX7C', 'BBC3', 'CASP8', 'LEPR', 'MLX', 'UQCRFS1', 'RAC1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'TNFRSF1A', 'NDUFS6', 'DDIT3', 'NDUFS5', 'UQCRC1', 'NDUFS3', 'NDUFS2', 'ATF4', 'CEBPA', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'COX7A2', 'PIK3R2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'NFKB1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",0.001148675579492375,0,0,60
6,Mitochondrial CIV Assembly WP4922,1.3852975544324583e-05,4.811192519039815,53.8228612648757,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX14', 'COX10']",0.001362209261858584,0,0,21
7,Exercise-induced Circadian Regulation WP410,0.00012549123153080623,3.1505440552016983,28.30220260817092,"['IDI1', 'DAZAP2', 'CEBPB', 'BTG1', 'GSTP1', 'TOB1', 'HERPUD1', 'PURA', 'PPP2CB', 'SUMO1', 'TUBB3', 'STBD1', 'SUMO3', 'ERC2', 'HSPA8', 'GSTM3', 'RBPMS', 'NCOA4', 'GFRA1', 'NR1D2', 'AZIN1', 'PER2', 'DNAJA1', 'KLF9', 'EIF4G2']",0.009616406011043495,0,0,25
8,Mitochondrial complex I assembly model OXPHOS system WP4324,0.00013039194591245418,2.959407975247639,26.47180275648011,"['NDUFA13', 'NDUFB7', 'NDUFB10', 'DMAC2', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'TMEM186', 'TMEM70', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFS2', 'NDUFAF3']",0.009616406011043495,0,0,27
9,"GPCRs, Class A Rhodopsin-like WP455",0.00018584636123169802,2.3902329686339883,20.533512012803207,"['GPR27', 'CHRM2', 'OXTR', 'CHRM1', 'GPR87', 'GPR22', 'CHRM5', 'HTR2B', 'OPRL1', 'GPR83', 'ADRB1', 'ADRA1D', 'MCHR1', 'LTB4R', 'GPER1', 'GPR171', 'P2RY12', 'GPR39', 'GPR12', 'HTR1E', 'HTR1F', 'P2RY14', 'SSTR1', 'GPR6', 'ADRA2C', 'SSTR2', 'HTR5A', 'SSTR3', 'HCRTR2', 'MAS1', 'CCKBR', 'ADORA2A', 'LPAR6', 'FSHR', 'ACKR4', 'RGL4']",0.012183261458522426,0,0,36
10,Computational Model of Aerobic Glycolysis WP4629,0.00037518831310299854,11.315406976744185,89.25686363780348,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'SLC2A1', 'ENO1', 'ALDOA', 'GAPDH', 'PFKM']",0.022136110473076915,0,0,9
11,Selenium Micronutrient Network WP15,0.0004789231287129905,2.738738115018924,20.934833238709043,"['TXN', 'SELENOK', 'PTGS2', 'SELENOH', 'PRDX3', 'PRDX2', 'PRDX5', 'RFK', 'PRDX1', 'PNPO', 'SEPHS2', 'GPX4', 'GPX3', 'DIO1', 'APOA1', 'HBA1', 'KMO', 'SOD2', 'NFKB1', 'SOD1', 'SELENOM', 'SELENOS', 'SELENOW', 'SELENOT', 'MSRB1']",0.025687695085514942,0,0,25
12,Myometrial relaxation and contraction pathways WP289,0.0006575555191724451,1.884114027777224,13.804868357250506,"['RYR1', 'YWHAE', 'OXTR', 'YWHAB', 'ATP2A2', 'RXFP1', 'ETS2', 'ACTB', 'ACTG1', 'RGS4', 'RGS2', 'YWHAQ', 'NOS1', 'YWHAG', 'YWHAH', 'PRKCG', 'PRKCH', 'IGFBP5', 'IGFBP4', 'GSTO1', 'IGFBP3', 'PDE4D', 'IGFBP2', 'PRKCD', 'FOS', 'YWHAZ', 'ACTA2', 'CREB3', 'CACNB3', 'ADCY9', 'PRKAR1A', 'PRKCQ', 'PRKD1', 'ATF5', 'ATF4', 'RGS19', 'RGS14', 'ITPR2', 'GNG3', 'GRK5', 'IGFBP6', 'CORIN', 'JUN', 'NFKB1', 'GNG13', 'ACTC1', 'GNB2', 'CALM3', 'CALM1', 'CALM2']",0.03232981302597855,0,0,50
13,IL-18 signaling pathway WP4754,0.001593334650753136,1.607916391961517,10.358078723644896,"['BTG2', 'CD83', 'CD81', 'HSPB8', 'ITGA2B', 'HSPB1', 'ENO1', 'RND2', 'PTMS', 'RPTOR', 'CASP8', 'ABHD16A', 'TMSB4X', 'STMN1', 'BSG', 'TIMP3', 'RPS11', 'IER3', 'TICAM2', 'USP5', 'IMP3', 'PRKCD', 'IL18', 'NDUFC1', 'FOS', 'TRAF1', 'BPGM', 'ARFGAP2', 'TNFRSF1A', 'ACTA2', 'ARL4D', 'RFX5', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'EPB41', 'MEPCE', 'COX17', 'PTGS2', 'PLD1', 'KLC1', 'ACACB', 'FUT1', 'CENPB', 'RXRB', 'IRAK1', 'MAPK1', 'FADD', 'MAPK3', 'CA11', 'SLC12A3', 'JUN', 'BAD', 'FN1', 'DEK', 'EEF2', 'NFKB1', 'NFKBIA', 'NR4A1', 'UCK1', 'NACA', 'CYCS', 'BAX', 'HDGF', 'NFKBIE', 'CDK5R2', 'AARS', 'ITM2C']",0.07147990017486894,0,0,70
14,Vitamin D Receptor Pathway WP2877,0.0016961332244884153,2.0793949468085104,13.265300841580757,"['COLEC11', 'CEBPA', 'CDKN1A', 'ABCB1', 'CDKN1B', 'SATB1', 'HILPDA', 'CLEC16A', 'PRDM1', 'CYP3A5', 'BGLAP', 'CREG2', 'TIMP2', 'TIMP3', 'SOSTDC1', 'JUNB', 'CDKN2D', 'G6PD', 'SERPINB1', 'CDKN2C', 'IGFBP5', 'GADD45A', 'CDKN2A', 'IGFBP3', 'NFATC2', 'MYO9B', 'CEACAM1', 'CDC34', 'TNFSF4', 'NINJ1', 'S100A6', 'PRKCQ', 'CLPTM1L']",0.07147990017486894,0,0,33
15,Proximal tubule transport WP4917,0.00229587354693441,2.8314238410596024,17.20554868530398,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'SLC47A1', 'ABCB1', 'SLC2A1', 'SLC3A1', 'SLC16A10', 'ATP1A1', 'ATP1B1', 'SLC7A9', 'CA4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.09030435951275347,0,0,18
16,Cori Cycle WP1946,0.0027160884321943296,5.6565142706131075,33.42186815717699,"['G6PD', 'LDHA', 'TPI1', 'PGAM1', 'SLC2A1', 'PGK1', 'GPT', 'ALDOA', 'GAPDH']",0.09808954080826252,0,0,9
17,HIF1A and PPARG regulation of glycolysis WP2456,0.002826308802949937,15.076841827303934,88.48272399462472,"['LDHA', 'TPI1', 'SLC2A1', 'GPAT3', 'PPARG', 'GAPDH']",0.09808954080826252,0,0,6
18,"GPCRs, Other WP117",0.0034807059449243837,2.6645890144137123,15.082959802312777,"['CHRM2', 'ADGRV1', 'HTR1F', 'GPR88', 'OR2M4', 'ADRA1D', 'GPR83', 'SSTR2', 'CELSR2', 'RXFP1', 'GPR162', 'CCKBR', 'ADORA2A', 'FSHR', 'ADGRF5', 'GNRHR', 'ACKR1', 'GPR135']",0.11408980597252147,0,0,18
19,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.003743987999142308,2.0742441996719005,11.590055033007772,"['PRKN', 'PSMD10', 'UBE2L6', 'PSMD8', 'TUBB8', 'TUBA1B', 'TUBB6', 'CASP8', 'TUBA1A', 'PSMD7', 'TUBB3', 'PSMD2', 'PSMD3', 'HSPA8', 'HSPA1L', 'HSPA5', 'TUBB', 'TUBB4B', 'TUBB4A', 'TUBA4A', 'PSMC5', 'TUBB2A', 'PSMC3', 'PSMC1', 'UBA1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.11626067997336641,0,0,28
20,Pathways in clear cell renal cell carcinoma WP4018,0.004428374738079176,1.9523325358851675,10.581100842657477,"['SHMT2', 'BHLHE41', 'SLC2A1', 'PDGFB', 'PLOD2', 'ENO1', 'ENO2', 'ACACB', 'ACACA', 'RPTOR', 'LDHB', 'LDHA', 'PGK1', 'KCNJ2', 'PDGFRA', 'TPI1', 'MDH1', 'ACLY', 'TOX2', 'PFKL', 'PKM', 'ZEB1', 'FASN', 'AKT1S1', 'ALDOC', 'ALDOB', 'CAMK1', 'ALDOA', 'GAPDH', 'PFKM', 'BAP1']",0.13063705477333568,0,0,31
21,Apoptosis Modulation and Signaling WP1772,0.005204353275863343,1.9740356722290835,10.379992488513569,"['HRK', 'HTRA2', 'BBC3', 'CASP8', 'CAPNS1', 'IRAK1', 'CASP6', 'PEA15', 'FADD', 'MAPK3', 'DAXX', 'JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'BNIP3', 'FOS', 'NFKB1', 'TNFRSF1A', 'NFKBIA', 'TRAF3', 'PTRH2', 'TOLLIP', 'CYCS', 'BAX', 'PRKD1', 'BCL2L2', 'HSPA1A']",0.14621754441711296,0,0,29
22,Imatinib and Chronic Myeloid Leukemia WP3640,0.0056864891655868935,4.524735729386892,23.391355444508612,"['PDGFRA', 'SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'ABL1', 'PIM1', 'GAB2', 'PIM2']",0.149713835526689,0,0,9
23,Metabolic reprogramming in colon cancer WP4290,0.005853686135541608,2.3906067832538422,12.289353341792998,"['G6PD', 'SHMT2', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A1', 'PYCR2', 'PDHB', 'ENO1', 'ACLY', 'LDHA', 'PFKL', 'PKM', 'FASN', 'PGK1', 'ALDOB', 'TKT', 'SLC16A3', 'GAPDH']",0.149713835526689,0,0,19
24,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.006090054326509383,1.468031074471146,7.488570784113638,"['CHRM2', 'CDKN1A', 'CRTC2', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'ITGA2B', 'SLC2A1', 'SLC2A3', 'HIF3A', 'FGF1', 'IGF1R', 'RPTOR', 'GYS2', 'GYS1', 'FGF7', 'PPP2R1A', 'CREB3L2', 'TNR', 'IKBKG', 'NOS1', 'JAK2', 'PELO', 'HRAS', 'RAB8A', 'IFNAR2', 'PDGFRA', 'MAP2K1', 'HSP90AA1', 'ITGA4', 'PDPK1', 'RPS6', 'PPP2R5D', 'TBC1D1', 'CREB3', 'CDC37', 'DDIT4', 'AKT1S1', 'ATF4', 'ITGA9', 'LAMA2', 'EPAS1', 'COL11A1', 'LAMA4', 'LAMA3', 'PDGFB', 'PIK3R2', 'ACACA', 'THBS4', 'HSP90B1', 'PPP2CA', 'PPP2CB', 'GNG10', 'GNG3', 'PDGFD', 'MAPK1', 'FGF22', 'EIF4B', 'MAPK3', 'ANGPT2', 'BAD', 'FN1', 'VEGFD', 'EPOR', 'GNG13', 'EFNA1', 'FGF17', 'EFNA3', 'FGF14', 'RAB14', 'LPAR6', 'GNB2', 'ITGA10', 'FGF12', 'FGF10']",0.149713835526689,0,0,75
25,miR-517 relationship with ARCN1 and USP1 WP3596,0.006587528575683301,inf,inf,"['CDKN1A', 'ID2', 'USP1', 'ARCN1']",0.1554656743861259,0,0,4
26,Aryl Hydrocarbon Receptor Pathway WP2873,0.007184954675225769,2.972053872053872,14.669362653121613,"['HSP90AA1', 'JUN', 'CDKN1B', 'JUND', 'PTGES3', 'MGST1', 'AIP', 'SLC7A5', 'CDC37', 'CYP1B1', 'AHRR', 'BAX', 'JUNB']",0.16304320224550783,0,0,13
27,Nuclear Receptors Meta-Pathway WP2882,0.009736332285614664,1.4479113001589587,6.706567022164692,"['CDKN1B', 'HSP90AB1', 'SRXN1', 'SLC2A1', 'KEAP1', 'SLC2A3', 'SLC2A8', 'RGS2', 'FTH1', 'ENC1', 'SLC39A6', 'CYP1B1', 'SLC39A7', 'JUNB', 'SLC39A1', 'SLC39A3', 'CBR1', 'ABCG8', 'G6PD', 'HSP90AA1', 'SLC6A16', 'GPX3', 'TSC22D3', 'SLC2A12', 'SLC39A11', 'AIP', 'APOA1', 'NRG1', 'SLC7A5', 'KAT2B', 'CDC37', 'B3GNT5', 'AHRR', 'FKBP5', 'FTL', 'ABCB1', 'GSTP1', 'AMIGO2', 'PDGFB', 'MGST1', 'MGST2', 'TXN', 'PTGS2', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'PTPA', 'FGD4', 'DNAJB1', 'PRDX1', 'GSTM4', 'EGR1', 'GSTM3', 'JUN', 'JUND', 'GADD45B', 'SLC10A1', 'PLK2', 'PTGES3', 'PRDX6', 'SLC2A9', 'SLC6A6', 'PSMC5', 'SLC6A8', 'ETNK2', 'FASN', 'BHLHE40', 'BAX', 'SPRY1', 'HSPA1A']",0.2079878596040862,0,0,70
28,NRF2 pathway WP2884,0.009870610286295616,1.7286520781809265,7.983249955433173,"['HSP90AB1', 'SRXN1', 'GSTP1', 'PDGFB', 'SLC2A1', 'KEAP1', 'MGST2', 'SLC2A3', 'TXN', 'SLC5A3', 'SLC2A8', 'DNAJB1', 'FTH1', 'PRDX1', 'SLC39A6', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'GSTM4', 'GSTM3', 'EGR1', 'CBR1', 'G6PD', 'HSP90AA1', 'SLC6A16', 'GPX3', 'SLC2A12', 'SLC39A11', 'NRG1', 'PRDX6', 'SLC2A9', 'SLC6A6', 'SLC6A8', 'FTL', 'HSPA1A']",0.2079878596040862,0,0,35
29,Mitochondrial complex III assembly WP4921,0.010644914829550847,3.7702167019027484,17.126861546700336,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRC1', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.21656895687706895,0,0,9
30,Pathogenic Escherichia coli infection WP2272,0.011288148267917682,2.172821216938864,9.742934529244017,"['TUBB', 'ARPC5L', 'ARPC4', 'ARPC5', 'TUBB4B', 'YWHAZ', 'TUBB4A', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1B', 'TUBB6', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'TUBB3', 'NCL', 'ABL1']",0.22200024926904777,0,0,19
31,VEGFA-VEGFR2 Signaling Pathway WP3888,0.011888263182167489,1.3008213935530275,5.765505332118469,"['RPL5', 'TRAF3IP2', 'ARPC5L', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'TUBB8', 'RPS6KA5', 'RPL18A', 'CFL1', 'BSG', 'CHAC1', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'MAP2K1', 'IGFBP3', 'PRKCD', 'RPS6', 'SARS', 'INPP4B', 'RAB37', 'KATNAL2', 'NCL', 'FSCN1', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V0D1', 'DSC1', 'ATF4', 'LRRC59', 'SET', 'EPB41', 'NOTCH4', 'PIK3R2', 'FOXO4', 'TXN', 'ACACB', 'NDRG1', 'FUT1', 'ACACA', 'PRDX2', 'STIP1', 'SDCBP', 'LDHA', 'PGK1', 'ABL1', 'INPP5K', 'FADD', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'FN1', 'NFATC2', 'TRIP4', 'BMX', 'PRDX6', 'NFKB1', 'NFKBIA', 'NR4A1', 'NR4A3', 'CYCS', 'HYOU1', 'CALR', 'GRSF1', 'EIF4G2', 'EIF4G1', 'YWHAE', 'CLTC', 'HSPB1', 'NRARP', 'SHB', 'HERPUD1', 'RND1', 'CSRP2', 'TMSB4X', 'RACK1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'RAC1', 'ACP1', 'HRAS', 'DUSP5', 'HSP90AA1', 'SSR4', 'PDPK1', 'GAB1', 'RPL13A', 'EPN1', 'VAV2', 'RCN1', 'AKT1S1', 'TKT', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'FJX1', 'ARF6', 'CRIP2', 'PTGS2', 'APOLD1', 'PPP2CA', 'DNAJB4', 'AP2S1', 'DNAJB9', 'MAPK1', 'FLNB', 'CCT7', 'ABCF2', 'MAPK3', 'STAT1', 'SOD2', 'RAB11A', 'DNAJA1', 'PTPN9', 'P4HB', 'HSPA1A']",0.22626049282189736,0,0,124
32,Senescence and Autophagy in Cancer WP615,0.014074316899155791,1.7344911099297065,7.39483570998078,"['CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'PCNA', 'BMI1', 'ING1', 'GABARAP', 'IGF1R', 'MAP1LC3B', 'ING2', 'MAP1LC3A', 'LAMP1', 'E2F1', 'MAPK1', 'SLC39A1', 'HRAS', 'SLC39A3', 'GABARAPL2', 'GABARAPL1', 'MAP2K1', 'JUN', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'HMGA1', 'RSL1D1', 'AKT1S1', 'FKBP8', 'IL6ST']",0.2465501788028786,0,0,31
33,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.014086599349260605,2.7427087591065376,11.690882026487154,"['RAB3B', 'FGD4', 'EGR2', 'RAB3A', 'HSPB8', 'HSPB1', 'NEFL', 'MFN2', 'RABAC1', 'NDRG1', 'RAB11A', 'DNM2']",0.2465501788028786,0,0,12
34,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.014426731405006672,3.1420169177901136,13.317980533404336,"['H3F3B', 'H2AFZ', 'H3F3A', 'H2AFX', 'MAPK1', 'PCGF1', 'H2AFV', 'DUSP6', 'MAPK3', 'EZH2']",0.2465501788028786,0,0,10
35,Calcium Regulation in the Cardiac Cell WP536,0.014625858064577543,1.5532667651057732,6.562496501255374,"['CHRM2', 'RYR1', 'YWHAE', 'GNAZ', 'CHRM1', 'RGS19', 'RGS14', 'YWHAB', 'CHRM5', 'CACNA1A', 'ITPR2', 'ATP2A2', 'ADRB1', 'ADRA1D', 'CACNA1C', 'RGS4', 'RGS2', 'GNG3', 'PLN', 'GRK5', 'YWHAQ', 'YWHAG', 'YWHAH', 'PRKCG', 'PRKCH', 'PRKCD', 'ATP1B1', 'YWHAZ', 'GNG13', 'CACNB1', 'GJD2', 'FKBP1A', 'SLC8A3', 'CACNB3', 'ADCY9', 'PRKAR1A', 'GNB2', 'PRKCQ', 'CALM3', 'PRKD1', 'CALR', 'CASQ1', 'CAMK1', 'CALM1', 'CALM2']",0.2465501788028786,0,0,45
36,Glycolysis in senescence WP5049,0.016127878561615933,4.397187004754358,18.148096223224552,"['LDHA', 'G6PD', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.2643180097598167,0,0,7
37,Methionine De Novo and Salvage Pathway WP3580,0.01824600207582582,3.2312745394140743,12.937407010689931,"['MSRA', 'AHCY', 'CHDH', 'AMD1', 'ODC1', 'TXN', 'MAT2B', 'ENOPH1', 'SRM']",0.29094976283073604,0,0,9
38,Peptide GPCRs WP24,0.020988254122617876,2.5138852155514413,9.713130402369584,"['OXTR', 'CCKBR', 'FSHR', 'GNRHR', 'OPRL1', 'TAC4', 'SSTR1', 'ACKR1', 'SSTR2', 'SSTR3', 'TSHR', 'HCRTR2']",0.322829767185442,0,0,12
39,Complement system WP2806,0.02231981823439134,2.117637222524142,8.051850262245424,"['PRNP', 'FKBP2', 'PROS1', 'F12', 'ITGA2B', 'APOA1', 'TXN', 'C2', 'SELP', 'GNA15', 'RPS19', 'C1QBP', 'SERPING1', 'CD59', 'CALR', 'KLKB1']",0.322829767185442,0,0,16
40,Monoamine GPCRs WP58,0.022793154901944494,2.792610215290628,10.559683076691963,"['CHRM2', 'CHRM1', 'HTR1E', 'HTR1F', 'CHRM5', 'HTR2B', 'ADRB1', 'ADRA1D', 'HTR5A', 'ADRA2C']",0.322829767185442,0,0,10
41,NAD Biosynthesis II (from tryptophan) WP2485,0.022981102070828072,6.279699049630412,23.693826042546046,"['TDO2', 'NMNAT1', 'HAAO', 'KMO', 'NADSYN1']",0.322829767185442,0,0,5
42,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.022981102070828072,6.279699049630412,23.693826042546046,"['JUN', 'IRAK1', 'TIFA', 'UBE2N', 'NFKB1']",0.322829767185442,0,0,5
43,Glycogen Synthesis and Degradation WP500,0.029785368733931505,2.0115435530844588,7.068036997240365,"['GSK3A', 'PHKA1', 'PPP2R5D', 'PHKA2', 'PPP2CA', 'GYS2', 'PTPA', 'PPP2CB', 'GYS1', 'PHKG1', 'PPP2R1A', 'CALM3', 'GYG2', 'CALM1', 'GYG1', 'CALM2']",0.40868296634929274,0,0,16
44,Complement and Coagulation Cascades WP558,0.03416485743516244,2.513084853291039,8.48557607141953,"['CPB2', 'SERPIND1', 'PROS1', 'F12', 'CLTC', 'SERPING1', 'CLU', 'KLKB1', 'F5', 'C2']",0.4479392419276853,0,0,10
45,Urea cycle and associated pathways WP4595,0.03416485743516244,2.513084853291039,8.48557607141953,"['SLC25A15', 'LDHB', 'OAT', 'MDH1', 'GOT1', 'CPS1', 'MDH2', 'GOT2', 'GPT', 'NOS1']",0.4479392419276853,0,0,10
46,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.04452524440227181,2.0422123015873015,6.354749896417496,"['MAP2K1', 'STAT1', 'RPS6', 'GAB2', 'NFKB1', 'RELB', 'NFKBIA', 'TEC', 'FES', 'TNFSF4', 'MAPK1', 'JAK2', 'MAPK3']",0.571084656463921,0,0,13
47,TP53 network WP1742,0.04810850872915686,2.930841697481951,8.893041886604646,"['CDKN1A', 'SUMO1', 'CDKN2A', 'GADD45A', 'ABL1', 'BAX', 'BBC3']",0.6003483197528519,0,0,7
48,Metapathway biotransformation Phase I and II WP702,0.048841897200232014,1.4827745060790274,4.476743538814488,"['GAL3ST1', 'NAA20', 'GSTP1', 'MGST1', 'MGST2', 'GLYAT', 'HS6ST1', 'CYP2C18', 'NAT14', 'CYP3A5', 'HS6ST2', 'NAA80', 'CYP3A7', 'CYP26B1', 'CYP1B1', 'SULT4A1', 'GAL3ST3', 'GSTM4', 'CHST8', 'GSTM3', 'CHST9', 'GLYATL2', 'GPX4', 'GPX3', 'GSTO1', 'KCNAB3', 'FMO5', 'HS3ST4', 'HS3ST1', 'CYP39A1', 'CHST1', 'NAT8L', 'CHST2']",0.6003483197528519,0,0,33
49,Aryl Hydrocarbon Receptor Netpath WP2586,0.049959326564114115,1.8282908513250054,5.478557771419208,"['CDKN1A', 'HSP90AA1', 'MAP2K1', 'CDKN1B', 'AIP', 'LPL', 'PTGS2', 'NFKB1', 'KLF6', 'PSRC1', 'CDC37', 'E2F1', 'MAPK1', 'CYP1B1', 'AHRR', 'HRAS']",0.6015510749556597,0,0,16
50,Translation Factors WP107,0.0528353446150356,1.6762964926230233,4.929275402286031,"['EIF4A2', 'EIF5A', 'EIF2B2', 'EIF1AY', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF6', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3G', 'EIF3CL', 'EIF4B', 'EIF4G1']",0.6147294172603971,0,0,20
51,PI3K-Akt signaling pathway WP4172,0.05313762759369534,1.28732224816734,3.7781234260122885,"['CHRM2', 'CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'FLT3', 'ITGA2B', 'FGF1', 'IGF1R', 'RPTOR', 'GYS2', 'GYS1', 'FGF7', 'PPP2R1A', 'CREB3L2', 'TNR', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'IFNAR2', 'PDGFRA', 'MAP2K1', 'HSP90AA1', 'ITGA4', 'PDPK1', 'RPS6', 'PPP2R5D', 'CREB3', 'CCNE2', 'CDC37', 'DDIT4', 'COL4A3', 'COL6A6', 'ATF4', 'ITGA9', 'LAMA2', 'LAMA4', 'LAMA3', 'PDGFB', 'PIK3R2', 'THBS4', 'HSP90B1', 'PPP2CA', 'PPP2CB', 'GNG10', 'GNG3', 'PDGFD', 'MAPK1', 'FGF22', 'EIF4B', 'MAPK3', 'ANGPT2', 'BDNF', 'BAD', 'FN1', 'VEGFD', 'NFKB1', 'EPOR', 'GNG13', 'EFNA1', 'FGF17', 'EFNA3', 'FGF14', 'LPAR6', 'IL7', 'GNB2', 'ITGA10', 'FGF12', 'FGF10']",0.6147294172603971,0,0,70
52,Proteoglycan biosynthesis WP4784,0.056442329752728844,2.5122853368560105,7.221654327653373,"['EXT1', 'SLC35B2', 'CANT1', 'B3GAT3', 'IMPAD1', 'XYLT1', 'B3GALT6', 'B4GALT7']",0.6168981896890859,0,0,8
53,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.05865456417944026,1.9218798630563336,5.450624042276946,"['PRKCG', 'MAP2K1', 'PRKCH', 'PRKCD', 'NFKB1', 'STAR', 'FSHR', 'MAPK1', 'PRKCQ', 'AMH', 'HRAS', 'PLCB2', 'MAPK3']",0.6168981896890859,0,0,13
54,Cellular Proteostasis WP4918,0.05913342398481562,5.022433359725521,14.203235444618555,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.6168981896890859,0,0,4
55,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.05913342398481562,5.022433359725521,14.203235444618555,"['HSD11B1', 'HSD11B2', 'H6PD', 'STAR']",0.6168981896890859,0,0,4
56,EDA signaling in hair follicle development WP3930,0.05913342398481562,5.022433359725521,14.203235444618555,"['EDA', 'PTCH1', 'SOSTDC1', 'RELB']",0.6168981896890859,0,0,4
57,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.062333962798320604,3.014100871402165,8.364879984611402,"['CDK8', 'JAG1', 'CSRP2', 'E2F1', 'TULP3', 'SOX4']",0.6168981896890859,0,0,6
58,RAS and bradykinin pathways in COVID-19 WP4969,0.062333962798320604,3.014100871402165,8.364879984611402,"['F12', 'MAPK1', 'SERPING1', 'NOS1', 'KLKB1', 'NFKB1']",0.6168981896890859,0,0,6
59,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.062333962798320604,3.014100871402165,8.364879984611402,"['STAG1', 'PTTG1', 'RAD21', 'BUB3', 'ANAPC11', 'MAD2L1']",0.6168981896890859,0,0,6
60,Canonical and non-canonical Notch signaling WP3845,0.06273540912092399,2.261178646934461,6.260817581578976,"['JAG1', 'MAML2', 'HEY1', 'MAML1', 'CNTN6', 'NOTCH4', 'DLL1', 'DLL3', 'DLK2']",0.6168981896890859,0,0,9
61,Nucleotide GPCRs WP80,0.07275538412550893,7.5324538258575195,19.739942948586336,"['ADORA2A', 'LPAR6', 'LTB4R']",0.692349623129843,0,0,3
62,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.07275538412550893,7.5324538258575195,19.739942948586336,"['ATP4A', 'CHRM1', 'CCKBR']",0.692349623129843,0,0,3
63,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.07750228368660049,1.5711966604823748,4.018253562338068,"['ITGA4', 'LAMA2', 'ITGA2B', 'TCF7', 'CACNA2D3', 'ATP2A2', 'CACNA1C', 'ACTB', 'ACTG1', 'CACNB1', 'CACNB3', 'ITGA10', 'LMNA', 'PKP2', 'CTNNA3', 'CTNNA2', 'CACNG2', 'EMD', 'SGCG', 'ITGA9']",0.7185274773656406,0,0,20
64,G1 to S cell cycle control WP45,0.07794196364644237,1.592059706765589,4.06260328898068,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'CDKN2A', 'GADD45A', 'PRIM1', 'CCNA1', 'CREB3', 'CCNB1', 'CCNE2', 'TFDP2', 'RPA3', 'POLE2', 'CCNG2', 'MCM3', 'E2F1', 'MCM4']",0.7185274773656406,0,0,19
65,Gastric acid production WP2596,0.08119445765216159,inf,inf,"['CCK', 'MUC6']",0.7212830454354391,0,0,2
66,Nanomaterial-induced inflammasome activation WP3890,0.08119445765216159,inf,inf,"['NFKB1', 'CTSB']",0.7212830454354391,0,0,2
67,Pyrimidine metabolism WP4022,0.08190841363419393,1.4369948776323278,3.5955818528265593,"['PRIM1', 'TYMP', 'NT5C', 'POLD4', 'POLR2C', 'POLR2D', 'POLD2', 'POLR2E', 'POLR2I', 'POLR2J', 'POLR2K', 'POLR2L', 'ENTPD1', 'RRM2', 'NME2', 'NME3', 'DCK', 'NME1', 'POLE4', 'UCK1', 'RRM2B', 'POLE2', 'POLE3', 'POLR1E', 'CMPK2', 'POLR3H', 'DCTPP1', 'POLR3K']",0.7212830454354391,0,0,28
68,Alzheimer's disease WP2059,0.0860848479104722,1.4618204710413272,3.585000486605493,"['ATP5MD', 'ATP2A2', 'ITPR2', 'LPL', 'CACNA1C', 'APH1A', 'CASP8', 'CHP1', 'MAPK1', 'NOS1', 'CAPN1', 'FADD', 'APBB1', 'MAPK3', 'PSENEN', 'BAD', 'TNFRSF1A', 'CDK5', 'CYCS', 'CALM3', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'CDK5R1']",0.7328319737389504,0,0,25
69,Prolactin Signaling Pathway WP2037,0.08874292449300851,1.4826497993606746,3.590994979914699,"['MAP2K1', 'JUN', 'STAT1', 'RPS6', 'PIK3R2', 'FOS', 'GAB2', 'ELK1', 'YWHAZ', 'NFKB1', 'VAV2', 'NFKBIA', 'TEC', 'RPS6KA2', 'SIRPA', 'MAPK1', 'RAC1', 'JAK2', 'PPIB', 'CTSD', 'HRAS', 'YWHAG', 'MAPK3']",0.7328319737389504,0,0,23
70,Pre-implantation embryo WP3527,0.08988328258012417,1.9325321783688159,4.655940223106822,"['EGR1', 'BATF3', 'ARGFX', 'DDIT3', 'CELF3', 'AQP9', 'HMGA1', 'FOSB', 'ATP1A1', 'HNRNPAB']",0.7328319737389504,0,0,10
71,Folate Metabolism WP176,0.09246626793137358,1.8424466772430812,4.386702246123252,"['AHCY', 'GPX4', 'GPX3', 'SHMT2', 'RFK', 'APOA1', 'NOS1', 'HBA1', 'SOD2', 'NFKB1', 'SOD1']",0.7328319737389504,0,0,11
72,Nuclear receptors WP170,0.09246626793137358,1.8424466772430812,4.386702246123252,"['RXRB', 'NR4A1', 'AR', 'THRA', 'ESRRB', 'NR2F1', 'RARB', 'NR1D2', 'ROR1', 'PPARG', 'NR2F6']",0.7328319737389504,0,0,11
73,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.093329897050863,1.5405405405405406,3.6535687189417385,"['FZD1', 'CDKN1A', 'MAP2K1', 'JUN', 'CDKN1B', 'FN1', 'ELK1', 'SOD1', 'PPP2CA', 'ERBB4', 'TMSB4X', 'NEFL', 'PFN4', 'MAPK1', 'NEFM', 'NOS1', 'CAMK1', 'NEFH', 'PFN2']",0.7328319737389504,0,0,19
74,Vitamin A and carotenoid metabolism WP716,0.09415541172721377,1.7735737511084837,4.19061521552692,"['RXRB', 'ABCG8', 'ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'ALDH1A1', 'LPL', 'MAPK1', 'RARB', 'BCO1']",0.7328319737389504,0,0,12
75,Synaptic Vesicle Pathway WP2267,0.09493310898422117,1.5824113308223478,3.7259184250843793,"['NSF', 'RAB3A', 'CLTC', 'CACNA1A', 'PARK7', 'SYP', 'SYN3', 'CPLX2', 'DNM2', 'STX1B', 'CLTCL1', 'AP2S1', 'SLC17A6', 'SLC17A7', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.7328319737389504,0,0,17
76,Ganglio Sphingolipid Metabolism WP1423,0.09538252725906973,2.511486664906258,5.901641727207675,"['ST8SIA1', 'B3GALT1', 'B3GALT4', 'B4GALNT1', 'FUT1', 'ST6GALNAC6']",0.7328319737389504,0,0,6
77,IL-6 signaling pathway WP364,0.09564078301338844,1.6752227220605098,3.9320089785446153,"['MAP2K1', 'STAT1', 'BAD', 'PRKCD', 'GAB1', 'PIK3R2', 'PRDM1', 'NR2F6', 'MAPK1', 'RAC1', 'JAK2', 'IL6ST', 'JUNB', 'MAPK3']",0.7328319737389504,0,0,14
78,Bile acids synthesis and enterohepatic circulation  WP4389,0.10733655767261482,3.347937010644849,7.471878889407891,"['ABCG8', 'SLC10A1', 'MAPK1', 'MAPK3']",0.7653200677594132,0,0,4
79,Dual hijack model of Vif in HIV infection WP3300,0.10733655767261482,3.347937010644849,7.471878889407891,"['UBB', 'ELOB', 'ELOC', 'RUNX1']",0.7653200677594132,0,0,4
80,Osteoblast Signaling WP322,0.10733655767261482,3.347937010644849,7.471878889407891,"['PDGFRA', 'BGLAP', 'PDGFB', 'PTH1R']",0.7653200677594132,0,0,4
81,Small cell lung cancer WP4658,0.10774939679593273,1.3803504934510324,3.075347945394546,"['CDKN1A', 'CDKN1B', 'LAMA2', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3R2', 'PTGS2', 'FHIT', 'CKS1B', 'RXRB', 'CASP8', 'E2F1', 'IKBKG', 'SKP1', 'GADD45B', 'GADD45A', 'FN1', 'TRAF1', 'NFKB1', 'NFKBIA', 'CCNE2', 'TRAF3', 'COL4A3', 'CKS2', 'RARB', 'CYCS', 'BAX']",0.7653200677594132,0,0,28
82,Cell cycle WP179,0.10919532311411377,1.3384308510638299,2.9641117766060185,"['YWHAE', 'ANAPC13', 'CDKN1A', 'CDKN1B', 'PCNA', 'YWHAB', 'ANAPC10', 'CDC14B', 'ANAPC11', 'CCNB1', 'PTTG1', 'YWHAQ', 'RAD21', 'ABL1', 'E2F1', 'BUB3', 'YWHAG', 'SKP1', 'YWHAH', 'CDKN2D', 'CDKN2C', 'GADD45B', 'GADD45A', 'CDKN2A', 'YWHAZ', 'MAD2L2', 'CCNA1', 'STAG1', 'RBL1', 'CCNE2', 'TFDP2', 'MCM3', 'MCM4']",0.7653200677594132,0,0,33
83,Toll-like Receptor Signaling related to MyD88 WP3858,0.11025797586364428,2.0094055482166446,4.430603445901699,"['TICAM2', 'IRAK1', 'TRAF3', 'TOLLIP', 'MAPK1', 'IKBKG', 'NFKB1', 'RELB']",0.7653200677594132,0,0,8
84,TYROBP causal network in microglia WP3945,0.11025797586364428,2.0094055482166446,4.430603445901699,"['RBM47', 'IGSF6', 'ADAP2', 'CREB3L2', 'IL18', 'LHFPL2', 'SFT2D2', 'TGFBR1']",0.7653200677594132,0,0,8
85,Zinc homeostasis WP3529,0.11025797586364428,2.0094055482166446,4.430603445901699,"['SLC30A3', 'SLC39A6', 'SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'SLC39A3']",0.7653200677594132,0,0,8
86,Gastrin signaling pathway WP4659,0.11429638405511688,1.3438788978716383,2.914820036951353,"['CDKN1A', 'CDKN1B', 'PIK3R2', 'PTGS2', 'ELK1', 'KAT5', 'MAPK1', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'MAPK3', 'CHGA', 'EGR1', 'MAP2K1', 'JUN', 'PRKCH', 'JAG1', 'CDKN2A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'NFKB1', 'RHOB', 'NFKBIA', 'CCKBR', 'PRKCQ', 'PPARG', 'PRKD1', 'LAMTOR3']",0.7723929371445712,0,0,31
87,Photodynamic therapy-induced unfolded protein response WP3613,0.11622094401020072,1.794305351006382,3.8618155997306944,"['PPP1R15A', 'NARS', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1', 'BBC3', 'ATF4']",0.7723929371445712,0,0,10
88,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.11740750257454129,1.7271119777895294,3.6996542835711272,"['NFKBIA', 'NDUFA13', 'HSP90AA1', 'COPS6', 'CASP8', 'IL18', 'PRDM1', 'RAC1', 'NLRP1', 'IKBKG', 'AAMP']",0.7723929371445712,0,0,11
89,CAMKK2  Pathway WP4874,0.1178226514288329,1.6748655558494225,3.5818251690909104,"['RPTOR', 'FIS1', 'MAP1LC3A', 'WFS1', 'MAPK1', 'NFATC2', 'NOS1', 'RAC1', 'CAMK1', 'CALM1', 'CALM2', 'MAPK3']",0.7723929371445712,0,0,12
90,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1178226514288329,1.6748655558494225,3.5818251690909104,"['LDHA', 'PFKL', 'ANGPT2', 'PKM', 'IGFBP3', 'BNIP3', 'IGFBP2', 'SLC2A1', 'PGK1', 'BAX', 'SLC2A3', 'PTGS2']",0.7723929371445712,0,0,12
91,Development and heterogeneity of the ILC family WP3893,0.12562184330153692,2.511087645195354,5.209198909622411,"['NFIL3', 'IL7', 'ID2', 'IL18', 'TOX']",0.8056183429120302,0,0,5
92,Transcriptional cascade regulating adipogenesis WP4211,0.12562184330153692,2.511087645195354,5.209198909622411,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG']",0.8056183429120302,0,0,5
93,Proteasome Degradation WP183,0.1270729363296233,1.4360683048729697,2.962600376336318,"['PSMD10', 'H2AFZ', 'H2AFX', 'HLA-C', 'HLA-F', 'PSMB10', 'PSMD8', 'PSMB6', 'UCHL1', 'PSMC5', 'PSMD7', 'PSMB5', 'UBB', 'PSMC3', 'PSMD2', 'PSMC1', 'PSMD3', 'UBC', 'PSME1', 'UBA1']",0.8061616390804058,0,0,20
94,Tryptophan catabolism leading to NAD+ production WP4210,0.13590313091682274,2.1524765174091818,4.2959404428029995,"['NMNAT1', 'TDO2', 'HAAO', 'NMNAT3', 'KMO', 'NADSYN1']",0.8369411837898714,0,0,6
95,Type II diabetes mellitus WP1584,0.13590313091682274,2.1524765174091818,4.2959404428029995,"['SURF1', 'KCNJ11', 'PRKCD', 'CACNA1A', 'MAPK1', 'PHKA2']",0.8369411837898714,0,0,6
96,16p11.2 proximal deletion syndrome WP4949,0.1372975451713641,1.3763104711380574,2.7328087406428785,"['PCNA', 'DOC2A', 'IGFBP3', 'MVP', 'PPP2R5D', 'KIF22', 'SEZ6L2', 'CORO1A', 'NFKB1', 'PPP2CA', 'CCT6A', 'PPP2CB', 'CASP8', 'PPP2R1A', 'TCP1', 'TMEM219', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'CCT5', 'YPEL3', 'MAPK3']",0.8369411837898714,0,0,23
97,Urea cycle and metabolism of amino groups WP497,0.14171783048879527,1.9532781593003463,3.8165440018882357,"['GATM', 'OAT', 'CPS1', 'ODC1', 'PYCR3', 'CKB', 'SRM']",0.8369411837898714,0,0,7
98,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.14373700537938972,3.765831134564644,7.3048462627246025,"['COX8A', 'GSTP1', 'COX5A']",0.8369411837898714,0,0,3
99,LTF danger signal response pathway WP4478,0.14373700537938972,3.765831134564644,7.3048462627246025,"['IRAK1', 'MAPK1', 'NFKB1']",0.8369411837898714,0,0,3
100,IL-5 signaling pathway WP127,0.1445524216601514,1.5865476969334205,3.068562617085833,"['GSK3A', 'SPRED1', 'MAP2K1', 'JUN', 'STAT1', 'RPS6', 'MAPK1', 'PIK3R2', 'FOS', 'JAK2', 'ELK1', 'MAPK3']",0.8369411837898714,0,0,12
101,IL-7 signaling pathway WP205,0.14481985280213067,1.8265401705296025,3.529359100932297,"['MAP2K1', 'CDKN1B', 'STAT1', 'BAD', 'IL7', 'MAPK1', 'PIK3R2', 'MAPK3']",0.8369411837898714,0,0,8
102,Spinal Cord Injury WP2431,0.14520122413639938,1.333643943375067,2.5734456918429975,"['RTN4R', 'BTG2', 'CDKN1B', 'XYLT1', 'PTGS2', 'RTN4', 'LTB4R', 'TNFSF13B', 'ACAN', 'E2F1', 'MAPK1', 'NOS1', 'RAC1', 'ROS1', 'MAPK3', 'EGR1', 'GADD45A', 'BDNF', 'OMG', 'MIF', 'FOS', 'RHOB', 'SELP', 'FKBP1A', 'NR4A1', 'APEX1']",0.8369411837898714,0,0,26
103,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.14617616686770674,1.7388193202146691,3.3436500267124267,"['PPP2CA', 'CDKN1A', 'MAP2K1', 'RBL1', 'THRA', 'STAT1', 'MAPK1', 'PTH1R', 'MAPK3']",0.8369411837898714,0,0,9
104,Regulation of toll-like receptor signaling pathway WP1449,0.15930844292663024,1.304970587033784,2.3971175185490945,"['OTUD5', 'CUEDC2', 'PELI3', 'PELI2', 'PIK3R2', 'CASP8', 'IRAK1', 'TIFA', 'MAPK1', 'MAP3K8', 'FADD', 'RAC1', 'IKBKG', 'TMED7', 'MAPK3', 'IFNAR2', 'MAP2K1', 'JUN', 'TICAM2', 'FBXW5', 'STAT1', 'FOS', 'NFKB1', 'RNF41', 'NFKBIA', 'TRAF3', 'TOLLIP']",0.8369411837898714,0,0,27
105,Glucocorticoid Receptor Pathway WP2880,0.16063933533896027,1.4356064904118915,2.625140811871864,"['HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'PLK2', 'PTGES3', 'AMIGO2', 'PTGS2', 'FGD4', 'RGS2', 'ETNK2', 'B3GNT5', 'ENC1', 'BHLHE40', 'SPRY1']",0.8369411837898714,0,0,16
106,IL-4 signaling pathway WP395,0.16063933533896027,1.4356064904118915,2.625140811871864,"['CEBPA', 'CEBPB', 'STAT1', 'BAD', 'PIK3R2', 'FOS', 'GAB2', 'ELK1', 'NFKB1', 'NFKBIA', 'NFIL3', 'FES', 'MAPK1', 'JAK2', 'MAPK3', 'SOCS5']",0.8369411837898714,0,0,16
107,RANKL/RANK signaling pathway WP2018,0.16063933533896027,1.4356064904118915,2.625140811871864,"['MAP2K1', 'JUN', 'STAT1', 'MITF', 'PIK3R2', 'FOS', 'TRAF1', 'GAB2', 'NFKB1', 'RELB', 'NFKBIA', 'TRAF3', 'MAPK1', 'RAC1', 'IKBKG', 'MAPK3']",0.8369411837898714,0,0,16
108,Melanoma WP4685,0.1643917939544389,1.3530059548087119,2.442855921739996,"['CDKN1A', 'MAP2K1', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'MITF', 'PIK3R2', 'FOS', 'ELK1', 'ERBB4', 'E2F1', 'MAPK1', 'BAX', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'LAMTOR3', 'CALM2', 'MAPK3']",0.8369411837898714,0,0,21
109,PDGF Pathway WP2526,0.1675400120755053,1.465356796330599,2.6179083879821285,"['MAP2K1', 'JUN', 'STAT1', 'PDGFB', 'FOS', 'ELK1', 'NFKB1', 'VAV2', 'NFKBIA', 'ARFIP2', 'MAPK1', 'RAC1', 'HRAS', 'MAPK3']",0.8369411837898714,0,0,14
110,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.16766569909129939,2.510688836104513,4.483545864591163,"['JAG1', 'EPAS1', 'TCF7', 'WNT2']",0.8369411837898714,0,0,4
111,Blood Clotting Cascade WP272,0.16766569909129939,2.510688836104513,4.483545864591163,"['F8A1', 'F12', 'KLKB1', 'F5']",0.8369411837898714,0,0,4
112,Canonical NF-KB pathway WP4562,0.16766569909129939,2.510688836104513,4.483545864591163,"['NFKBIA', 'IKBKG', 'NFKBIE', 'NFKB1']",0.8369411837898714,0,0,4
113,IL1 and megakaryocytes in obesity WP2865,0.16766569909129939,2.510688836104513,4.483545864591163,"['IRAK1', 'IL18', 'TIMP2', 'NFKB1']",0.8369411837898714,0,0,4
114,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.16766569909129939,2.510688836104513,4.483545864591163,"['IRAK1', 'TIFA', 'UBE2N', 'NFKB1']",0.8369411837898714,0,0,4
115,Oncostatin M Signaling Pathway WP2374,0.17288682649264855,1.363903399197517,2.3938115162301115,"['EGR1', 'MAP2K1', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'STAT1', 'PRKCD', 'RPS6', 'FOS', 'NFKB1', 'NFKBIA', 'TIMP3', 'MAPK1', 'JAK2', 'IL6ST', 'JUNB', 'HRAS', 'MAPK3']",0.8369411837898714,0,0,19
116,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.17418666480614511,1.5070616239090189,2.633782742858464,"['NFKBIA', 'JUN', 'CASP8', 'TRAF3', 'TNFSF12', 'MAPK1', 'FADD', 'RAC1', 'TRAF1', 'NFKB1', 'RELB', 'MAPK3']",0.8369411837898714,0,0,12
117,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.1762641296870667,1.2390843196485994,2.1507674613469865,"['CHRM2', 'YWHAE', 'CEBPB', 'YWHAB', 'ATP1A3', 'HSP90B1', 'NEUROD1', 'YWHAQ', 'TPPP', 'PKNOX1', 'SCN3B', 'YWHAG', 'YWHAH', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'CAV3', 'BDNF', 'SSTR1', 'SSTR2', 'POU3F2', 'YWHAZ', 'NFKB1', 'GCK', 'ADCYAP1', 'AR', 'PRKAR1A', 'KCNQ1', 'BHLHE40', 'ALDOA', 'GAPDH', 'SCN4B', 'SLC25A4']",0.8369411837898714,0,0,35
118,Hypertrophy Model WP516,0.17836175640567345,2.0923530447025693,3.607094145437365,"['JUND', 'NR4A3', 'ZEB1', 'WDR1', 'IL18']",0.8369411837898714,0,0,5
119,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.17836175640567345,2.0923530447025693,3.607094145437365,"['ZEB1', 'IL6ST', 'JAK2', 'NFKB1', 'SOX4']",0.8369411837898714,0,0,5
120,Endothelin Pathways WP2197,0.18004744341470263,1.5696867565424266,2.6912827077873382,"['ADCY10', 'GNA15', 'MAP2K1', 'CALCRL', 'ATP2A2', 'MAPK1', 'ADRB1', 'CALM1', 'CALM2', 'GNG13']",0.8369411837898714,0,0,10
121,Genotoxicity pathway WP4286,0.1818822169126463,1.3776483050847457,2.348058207173907,"['PLK3', 'BTG2', 'CDKN1A', 'GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'TRIAP1', 'ACTA2', 'MEX3B', 'RPS27', 'RRM2B', 'BLOC1S2', 'ID2', 'B3GNT2', 'TRIM22', 'PHLDA3']",0.8369411837898714,0,0,17
122,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.1818822169126463,1.3776483050847457,2.348058207173907,"['PRKCG', 'IFI27L2', 'JUN', 'PRKCH', 'STAT1', 'PRKCD', 'ISG15', 'NFKB1', 'TNFRSF1A', 'RELB', 'RXRB', 'MAPK7', 'MAPK1', 'PRKCQ', 'HRAS', 'PLCB2', 'MAPK3']",0.8369411837898714,0,0,17
123,16p11.2 distal deletion syndrome WP4950,0.18236445487714958,1.614448051948052,2.7473838967328774,"['PLN', 'CD82', 'CD81', 'PRMT1', 'NFATC2', 'TRAF1', 'JAK2', 'TUFM', 'VAV2']",0.8369411837898714,0,0,9
124,Oxidative Stress WP408,0.18236445487714958,1.614448051948052,2.7473838967328774,"['GPX3', 'MGST1', 'NOX5', 'FOS', 'SOD2', 'JUNB', 'NFKB1', 'TXN2', 'SOD1']",0.8369411837898714,0,0,9
125,Sleep regulation WP3591,0.18236445487714958,1.614448051948052,2.7473838967328774,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'ADORA2A', 'IL18', 'GHRL', 'FOS', 'HCRTR2']",0.8369411837898714,0,0,9
126,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.18299612352335803,1.8832189067863745,3.198252419681221,"['EGLN2', 'PTGS2', 'NFKB1', 'BCL2L2', 'RELB', 'TNFRSF1A']",0.8369411837898714,0,0,6
127,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.18395887462748275,1.6741523557904008,2.8344120169972804,"['G6PD', 'MDH1', 'GOT1', 'MDH2', 'SCO2', 'GOT2', 'HMGA1', 'SLC2A1']",0.8369411837898714,0,0,8
128,Ebstein-Barr virus LMP1 signaling WP262,0.18441076930963268,1.7577654516640253,2.9716599349920347,"['NFKBIA', 'HSP90AA1', 'IRAK1', 'MAPK1', 'TRAF1', 'IKBKG', 'NFKB1']",0.8369411837898714,0,0,7
129,Nanomaterial induced apoptosis WP2507,0.18441076930963268,1.7577654516640253,2.9716599349920347,"['ENDOG', 'CASP8', 'CASP6', 'HTRA2', 'BAX', 'CYCS', 'FADD']",0.8369411837898714,0,0,7
130,Vitamin B12 metabolism WP1533,0.18441076930963268,1.7577654516640253,2.9716599349920347,"['CUBN', 'SHMT2', 'APOA1', 'HBA1', 'SOD2', 'NFKB1', 'SOD1']",0.8369411837898714,0,0,7
131,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.18658679027620967,1.3190416224814423,2.2144846153339786,"['EGR1', 'MAP2K1', 'JUN', 'CDKN1B', 'PDPK1', 'STAT1', 'PDE4D', 'KCNIP3', 'RPS6', 'PIK3R2', 'FOS', 'PLD1', 'TSHR', 'IGF1R', 'MYL12B', 'APEX1', 'E2F1', 'MAPK1', 'JAK2', 'HRAS', 'MAPK3']",0.8403527195646083,0,0,21
132,Effects of nitric oxide WP1995,0.19732443533840444,5.0203112635188605,8.147493396806567,"['HBA1', 'NOS1']",0.8589237332858375,0,0,2
133,Macrophage markers WP4146,0.19732443533840444,5.0203112635188605,8.147493396806567,"['CD74', 'CD83']",0.8589237332858375,0,0,2
134,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.19732443533840444,5.0203112635188605,8.147493396806567,"['NRP1', 'FURIN']",0.8589237332858375,0,0,2
135,Ferroptosis WP4313,0.20648487045976233,1.4351456530774171,2.2639826467062236,"['PRNP', 'MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'PCBP1', 'PCBP2', 'NCOA4', 'VDAC3', 'ACSL5', 'VDAC2', 'FTL']",0.8589237332858375,0,0,12
136,Parkinson's disease pathway WP2371,0.20648487045976233,1.4351456530774171,2.2639826467062236,"['PRKN', 'UCHL1', 'PINK1', 'UBB', 'CCNE2', 'CASP6', 'SYT11', 'HTRA2', 'CYCS', 'UBE2L6', 'UBA1', 'PARK7']",0.8589237332858375,0,0,12
137,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.21689446911703478,1.4771967470572687,2.257665318696808,"['CREB3', 'STAR', 'CREB3L2', 'ITPR2', 'CALM3', 'CAMK1', 'CALM1', 'PLCB2', 'CALM2', 'ATF4']",0.8589237332858375,0,0,10
138,Hepatitis B infection WP4666,0.21791097410835003,1.1920858250730455,1.816343829874379,"['CDKN1A', 'PCNA', 'YWHAB', 'PIK3R2', 'ELK1', 'CASP8', 'IRAK1', 'YWHAQ', 'CREB3L2', 'MAPK1', 'FADD', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3', 'PRKCG', 'MAP2K1', 'JUN', 'EGR2', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'STAT1', 'BAD', 'NFATC3', 'NFATC2', 'FOS', 'YWHAZ', 'NFKB1', 'TGFBR1', 'CREB3', 'TRAF3', 'VDAC3', 'CYCS', 'BAX', 'ATF4']",0.8589237332858375,0,0,37
139,Modulators of TCR signaling and T cell activation WP5072,0.22065058576682425,1.3455248430764577,2.0333233547600456,"['CDKN1B', 'NDUFB10', 'PDPK1', 'PIK3R2', 'RNF7', 'NFKB1', 'ZFP36L1', 'NFKBIA', 'FIBP', 'PCBP2', 'ELOB', 'MAP3K8', 'PRKCQ', 'IKBKG', 'MEF2D']",0.8589237332858375,0,0,15
140,Adipogenesis WP236,0.2213829445416852,1.2157852777039595,1.8332355648189822,"['CEBPA', 'CDKN1A', 'CEBPB', 'EPAS1', 'ASIP', 'LPL', 'CYP26B1', 'LMNA', 'E2F1', 'NDN', 'SPOCK1', 'MEF2D', 'FZD1', 'GDF10', 'WWTR1', 'EGR2', 'GADD45B', 'GADD45A', 'STAT1', 'HMGA1', 'NR2F1', 'MIF', 'BSCL2', 'SFRP4', 'BMP3', 'KLF6', 'RBL1', 'DDIT3', 'PPARG', 'IL6ST']",0.8589237332858375,0,0,30
141,Toll-like Receptor Signaling Pathway WP75,0.22277529599265922,1.2899067589051691,1.936913227250717,"['IFNAR2', 'MAP2K1', 'JUN', 'TICAM2', 'STAT1', 'PIK3R2', 'FOS', 'NFKB1', 'NFKBIA', 'CASP8', 'IRAK1', 'TRAF3', 'TOLLIP', 'MAPK1', 'MAP3K8', 'FADD', 'RAC1', 'IKBKG', 'MAPK3']",0.8589237332858375,0,0,19
142,Type II interferon signaling (IFNG) WP619,0.22702381545153386,1.5452088202418452,2.2910816634173434,"['CIITA', 'STAT1', 'PRKCD', 'IFI6', 'TAP1', 'ISG15', 'JAK2', 'IFIT2']",0.8589237332858375,0,0,8
143,Prader-Willi and Angelman Syndrome WP3998,0.22718166872399453,1.3523520670914162,2.0041929022571434,"['PCSK1', 'OCA2', 'MAGEL2', 'CDKN2C', 'CDKN2A', 'BDNF', 'TYR', 'GABRG3', 'FEZ1', 'E2F1', 'NDN', 'GNRH1', 'GHRL', 'GABRD']",0.8589237332858375,0,0,14
144,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.22718166872399453,1.3523520670914162,2.0041929022571434,"['MAP2K1', 'JUN', 'AHSA1', 'NFATC2', 'FOS', 'NFKB1', 'NFKBIA', 'CHP1', 'MAP3K8', 'PRKCQ', 'IKBKG', 'CALM1', 'CALM2', 'MAPK3']",0.8589237332858375,0,0,14
145,Drug Induction of Bile Acid Pathway WP2289,0.22834059536815915,2.5102902374670184,3.707490139285258,"['ABCB1', 'SLC10A1', 'SLC51A']",0.8589237332858375,0,0,3
146,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.22834059536815915,2.5102902374670184,3.707490139285258,"['CEBPB', 'ALDH1A1', 'ADH5']",0.8589237332858375,0,0,3
147,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.22834059536815915,2.5102902374670184,3.707490139285258,"['E2F1', 'BAX', 'IL6ST']",0.8589237332858375,0,0,3
148,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.22834059536815915,2.5102902374670184,3.707490139285258,"['AHCY', 'ADK', 'MAT2B']",0.8589237332858375,0,0,3
149,Peroxiredoxin 2 induced ovarian failure WP4873,0.22834059536815915,2.5102902374670184,3.707490139285258,"['PRDX2', 'STAR', 'BAX']",0.8589237332858375,0,0,3
150,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.22834059536815915,2.5102902374670184,3.707490139285258,"['NFKBIA', 'IKBKG', 'NFKB1']",0.8589237332858375,0,0,3
151,Apoptosis Modulation by HSP70 WP384,0.23159891201172336,1.59780050905249,2.3371798681049714,"['CASP8', 'CASP6', 'CYCS', 'FADD', 'NFKB1', 'TNFRSF1A', 'HSPA1A']",0.8589237332858375,0,0,7
152,Globo Sphingolipid Metabolism WP1424,0.23159891201172336,1.59780050905249,2.3371798681049714,"['B3GALNT1', 'ST8SIA1', 'FUT2', 'ST6GALNAC3', 'FUT1', 'ABO', 'ST6GALNAC6']",0.8589237332858375,0,0,7
153,Interleukin-11 Signaling Pathway WP2332,0.23400297643483758,1.3603284832451499,1.9757702598109503,"['MAP2K1', 'STAT1', 'PDPK1', 'RPS6', 'PIK3R2', 'PTPA', 'BGLAP', 'FES', 'MAPK1', 'JAK2', 'IL6ST', 'HRAS', 'MAPK3']",0.8589237332858375,0,0,13
154,Cholesterol Biosynthesis Pathway WP197,0.23538701285850858,1.6737963207464133,2.4211869779022073,"['IDI1', 'SQLE', 'HMGCS1', 'PMVK', 'MSMO1', 'DHCR7']",0.8589237332858375,0,0,6
155,Kynurenine Pathway and links to Cellular Senescence WP5044,0.23538701285850858,1.6737963207464133,2.4211869779022073,"['CDKN1A', 'TDO2', 'HAAO', 'NOS1', 'KMO', 'ACMSD']",0.8589237332858375,0,0,6
156,Matrix Metalloproteinases WP129,0.23669728150464475,2.0083399313803114,2.8939641130263856,"['MMP15', 'BSG', 'TIMP2', 'TIMP3']",0.8589237332858375,0,0,4
157,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.23669728150464475,2.0083399313803114,2.8939641130263856,"['JUN', 'MAPK1', 'PRKCQ', 'MAPK3']",0.8589237332858375,0,0,4
158,Airway smooth muscle cell contraction WP4962,0.23763263650088606,1.7932569014934379,2.576962785039564,"['RYR1', 'PPP1CB', 'GDI1', 'CALM1', 'CALM2']",0.8589237332858375,0,0,5
159,Cancer immunotherapy by PD-1 blockade WP4585,0.23763263650088606,1.7932569014934379,2.576962785039564,"['JUN', 'NFATC3', 'NFATC2', 'PDCD1LG2', 'NFKB1']",0.8589237332858375,0,0,5
160,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.23763263650088606,1.7932569014934379,2.576962785039564,"['CD63', 'CD81', 'HSPB1', 'ETS2', 'SOD1']",0.8589237332858375,0,0,5
161,Galanin receptor pathway WP4970,0.23763263650088606,1.7932569014934379,2.576962785039564,"['CDKN1A', 'CDKN1B', 'PRKCD', 'PPARG', 'FOS']",0.8589237332858375,0,0,5
162,Major receptors targeted by epinephrine and norepinephrine WP4589,0.23763263650088606,1.7932569014934379,2.576962785039564,"['ADCY10', 'ADCY9', 'ADRB1', 'ADRA1D', 'ADRA2C']",0.8589237332858375,0,0,5
163,miRNAs involved in DNA damage response WP1545,0.23763263650088606,1.7932569014934379,2.576962785039564,"['CDKN1A', 'CDKN1B', 'H2AFX', 'E2F1', 'ABL1']",0.8589237332858375,0,0,5
164,B Cell Receptor Signaling Pathway WP23,0.23875168179470735,1.2304026943757074,1.7623442359808783,"['MAP2K1', 'JUN', 'GSK3A', 'CD81', 'PDPK1', 'PRKCD', 'NFATC3', 'GAB1', 'NFATC2', 'PIK3R2', 'GAB2', 'ELK1', 'ILF2', 'NFKB1', 'RASGRP3', 'VAV2', 'NFKBIA', 'TEC', 'MAPK1', 'PIP5K1B', 'RAC1', 'IKBKG', 'HRAS', 'MEF2D']",0.8589237332858375,0,0,24
165,Oxidative Damage WP3941,0.24860142427680987,1.3811078794288736,1.9223700938283907,"['CDKN1A', 'PCNA', 'CDKN1B', 'BAD', 'GADD45A', 'TRAF3', 'CYCS', 'TRAF1', 'NFKBIE', 'NFKB1', 'C2']",0.8889384262019262,0,0,11
166,IL17 signaling pathway WP2112,0.2646251675307363,1.4123447410147991,1.87762888682389,"['CEBPB', 'TRAF3IP2', 'TRAF3', 'MAPK1', 'IKBKG', 'IL17RE', 'JAK2', 'NFKB1', 'MAPK3']",0.9349032864858348,0,0,9
167,Tryptophan metabolism WP465,0.2646251675307363,1.4123447410147991,1.87762888682389,"['ECHS1', 'TDO2', 'PRMT1', 'HAAO', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.9349032864858348,0,0,9
168,Apoptosis WP254,0.2695308680620444,1.2251362375802395,1.6062422545628094,"['HRK', 'JUN', 'CRADD', 'CDKN2A', 'BAD', 'TRAF1', 'NFKB1', 'IGF1R', 'BBC3', 'TNFRSF1A', 'NFKBIA', 'CASP8', 'CASP6', 'TRAF3', 'CYCS', 'BAX', 'IKBKG', 'FADD', 'NFKBIE', 'BCL2L2']",0.9465667390274178,0,0,20
169,Estrogen signaling pathway WP712,0.2732224686406742,1.434685789771655,1.8614602110110345,"['MAP2K1', 'JUN', 'GPER1', 'MAPK1', 'FOS', 'IKBKG', 'ELK1', 'NFKB1']",0.9538535887455489,0,0,8
170,IL-3 signaling pathway WP286,0.27776987098399325,1.3100743994572404,1.6781559294261332,"['MAP2K1', 'JUN', 'YWHAQ', 'YWHAB', 'BAD', 'MAPK1', 'PIK3R2', 'FOS', 'GAB2', 'JAK2', 'HRAS', 'MAPK3']",0.9640248463562119,0,0,12
171,TNF-alpha signaling pathway WP231,0.2798587331306085,1.1847534350839242,1.5087483451747152,"['TXN', 'PPP2CA', 'SMPD2', 'CASP8', 'PSMD2', 'RFK', 'MAPK1', 'MAP3K8', 'RAC1', 'IKBKG', 'FADD', 'HRAS', 'SKP1', 'MAPK3', 'HSP90AA1', 'JUN', 'BAD', 'TRAF1', 'KSR2', 'NFKB1', 'TNFRSF1A', 'NFKBIA', 'CDC37', 'BAX', 'NFKBIE']",0.9655944593395264,0,0,25
172,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.28222002559566695,1.464496390209544,1.8526879289284777,"['LDHA', 'RPS6', 'SLC2A1', 'KEAP1', 'PDHB', 'ACACB', 'ACACA']",0.9662894195891868,0,0,7
173,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.2849734898449466,inf,inf,['FMO5'],0.9662894195891868,0,0,1
174,EV release from cardiac cells and their functional effects WP3297,0.2849734898449466,inf,inf,['ERBB4'],0.9662894195891868,0,0,1
175,One-carbon metabolism WP241,0.2915885165279471,1.506258251914444,1.8563302334268066,"['AHCY', 'SHMT2', 'CHDH', 'DNMT3A', 'GLRX', 'MAT2B']",0.9772782145152683,0,0,6
176,miRNA regulation of prostate cancer signaling pathways WP3981,0.2980859574901705,1.3214240995033182,1.5994165618114522,"['NFKBIA', 'AR', 'CDKN1A', 'MAP2K1', 'CDKN1B', 'BAD', 'TCF7', 'MAPK1', 'IKBKG', 'NFKB1']",0.9772782145152683,0,0,10
177,Biomarkers for pyrimidine metabolism disorders WP4584,0.3012135698007238,1.5689347940865892,1.8826209199937949,"['NT5C', 'RRM2', 'RRM2B', 'CKB', 'TYMP']",0.9772782145152683,0,0,5
178,IL-9 signaling pathway WP22,0.3012135698007238,1.5689347940865892,1.8826209199937949,"['MAP2K1', 'STAT1', 'MAPK1', 'PIK3R2', 'MAPK3']",0.9772782145152683,0,0,5
179,Nicotine Activity on Dopaminergic Neurons WP1602,0.3012135698007238,1.5689347940865892,1.8826209199937949,"['CHRNB2', 'CDK5', 'PPP1R1B', 'SLC18A2', 'KCNK3']",0.9772782145152683,0,0,5
180,7q11.23 copy number variation syndrome WP4932,0.3030248421746001,1.1528443602638625,1.3764275597630589,"['PCNA', 'CLTC', 'ATP5MC2', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ACACA', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'WNT2', 'MAPK3', 'ATP5PB', 'H2AFX', 'HMGA1', 'VPS37D', 'NRG1', 'DEK', 'ATP5F1D', 'ATP5F1E', 'TBL2', 'DNAJC30', 'ATP5PO', 'GAPDH', 'ATF4']",0.9772782145152683,0,0,28
181,Alpha 6 Beta 4 signaling pathway WP244,0.3094016035814278,1.3291257306305186,1.5592175414664509,"['LAMA2', 'LAMA3', 'PRKCD', 'GAB1', 'MAPK1', 'PIK3R2', 'RAC1', 'HRAS', 'MAPK3']",0.9772782145152683,0,0,9
182,Dopamine metabolism WP2436,0.3107475631231639,1.673440661564177,1.9558745893290366,"['PPP2CA', 'PPP2CB', 'TYR', 'SOD1']",0.9772782145152683,0,0,4
183,Hedgehog Signaling Pathway Netpath WP47,0.3107475631231639,1.673440661564177,1.9558745893290366,"['GRK2', 'PTCH1', 'SUFU', 'SAP18']",0.9772782145152683,0,0,4
184,Nanoparticle triggered regulated necrosis WP2513,0.3107475631231639,1.673440661564177,1.9558745893290366,"['CASP8', 'FADD', 'TNFRSF1A', 'FTL']",0.9772782145152683,0,0,4
185,Osteopontin Signaling WP1434,0.3107475631231639,1.673440661564177,1.9558745893290366,"['MAP2K1', 'MAPK1', 'NFKB1', 'MAPK3']",0.9772782145152683,0,0,4
186,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3190936084076156,1.8825197889182057,2.150347340046319,"['LPL', 'APOA1', 'LDLRAP1']",0.9772782145152683,0,0,3
187,Supression of HMGB1 mediated inflammation by THBD WP4479,0.3190936084076156,1.8825197889182057,2.150347340046319,"['NFKBIA', 'IKBKG', 'NFKB1']",0.9772782145152683,0,0,3
188,Hematopoietic Stem Cell Differentiation WP2849,0.3216800682336276,1.3388991633641567,1.518576491235492,"['CIITA', 'ITGA2B', 'PIM1', 'NFATC2', 'FOSB', 'FOS', 'ABO', 'RUNX1']",0.9772782145152683,0,0,8
189,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.3218934535897989,2.509891849116328,2.845049448165611,"['TRAF3', 'NFKB1']",0.9772782145152683,0,0,2
190,Cells and molecules involved in local acute inflammatory response  WP4493,0.3218934535897989,2.509891849116328,2.845049448165611,"['SELP', 'ITGA4']",0.9772782145152683,0,0,2
191,Composition of Lipid Particles WP3601,0.3218934535897989,2.509891849116328,2.845049448165611,"['APOA1', 'LPL']",0.9772782145152683,0,0,2
192,Irinotecan pathway WP229,0.3218934535897989,2.509891849116328,2.845049448165611,"['ABCC1', 'CYP3A5']",0.9772782145152683,0,0,2
193,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.3218934535897989,2.509891849116328,2.845049448165611,"['DLL1', 'DLL3']",0.9772782145152683,0,0,2
194,Sulindac Metabolic Pathway WP2542,0.3218934535897989,2.509891849116328,2.845049448165611,"['MSRA', 'CYP1B1']",0.9772782145152683,0,0,2
195,Ebola Virus Pathway on Host WP4217,0.32737043329650367,1.1341301460823374,1.2664410870586125,"['CLTC', 'VPS4A', 'PIK3R2', 'ACTB', 'ASGR1', 'IGF1R', 'ACTG1', 'RELB', 'C1QBP', 'CLTCL1', 'MAPK1', 'FLNB', 'RAC1', 'CTSB', 'MAPK3', 'VPS18', 'CAV3', 'ITGA4', 'CAV2', 'STAT1', 'HLA-C', 'HLA-F', 'MERTK', 'NFKB1', 'RHOB', 'VAV2', 'TYRO3', 'HLA-DQB1']",0.9772782145152683,0,0,28
196,Allograft Rejection WP2328,0.32812842840699563,1.255288207297726,1.3988306613605848,"['PECR', 'PDGFRA', 'TUBA1B', 'CASP8', 'ABCB1', 'STAT1', 'HLA-C', 'HLA-F', 'MICA', 'HLA-DQB1', 'C2']",0.9772782145152683,0,0,11
197,Amyotrophic lateral sclerosis (ALS) WP2447,0.32812842840699563,1.255288207297726,1.3988306613605848,"['DAXX', 'BAD', 'DERL1', 'NEFL', 'BAX', 'NEFM', 'NOS1', 'RAC1', 'NEFH', 'SOD1', 'TNFRSF1A']",0.9772782145152683,0,0,11
198,p38 MAPK Signaling Pathway WP400,0.32812842840699563,1.255288207297726,1.3988306613605848,"['DAXX', 'RPS6KA5', 'STAT1', 'DDIT3', 'HSPB1', 'RAC1', 'ELK1', 'HRAS', 'MEF2D', 'TGFBR1', 'HMGN1']",0.9772782145152683,0,0,11
199,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.3296243469297261,1.2120703342427754,1.3451576151184987,"['EIF4A2', 'MAP2K1', 'PRKCD', 'RPS6', 'PIK3R2', 'RPTOR', 'RPS6KA5', 'RPS6KA2', 'PIM1', 'MAPK1', 'PIM2', 'EIF4B', 'MAPK3', 'EIF4G1']",0.9772782145152683,0,0,14
200,Base Excision Repair WP4752,0.34128852263592163,1.2552207242928892,1.349396234857207,"['POLE4', 'POLD4', 'FEN1', 'PCNA', 'NEIL2', 'APEX1', 'POLE2', 'POLD2', 'POLE3', 'APEX2']",0.9999941002753671,0,0,10
201,Bladder cancer WP2828,0.34128852263592163,1.2552207242928892,1.349396234857207,"['CDKN1A', 'MAP2K1', 'RPS6KA5', 'CDKN2A', 'DAPK2', 'E2F1', 'MAPK1', 'PIK3R2', 'HRAS', 'TYMP']",0.9999941002753671,0,0,10
202,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3500490933567553,1.369181650142833,1.4372051516077005,"['RAB5B', 'RAB5C', 'RAB27A', 'MAPK1', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,6
203,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.3500490933567553,1.369181650142833,1.4372051516077005,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3G', 'EIF3CL', 'EIF1']",0.9999941002753671,0,0,6
204,Cardiac Hypertrophic Response WP2795,0.3528072915674131,1.1768379433562732,1.2260689432109493,"['MAP2K1', 'PDPK1', 'NFATC2', 'NRG1', 'TGFBR1', 'NFKB1', 'TNFRSF1A', 'MAPK7', 'MAPK1', 'RAC1', 'IKBKG', 'PRKD1', 'CALM1', 'CALM2', 'MAPK3']",0.9999941002753671,0,0,15
205,Acute viral myocarditis WP4298,0.36150787642157856,1.1535158039395328,1.1736693970046062,"['ENDOG', 'LAMA2', 'STAT1', 'ACTB', 'CASP8', 'CASP6', 'ABL1', 'RAC3', 'MAPK1', 'CYCS', 'BAX', 'NOS1', 'SGCG', 'MICA', 'EIF4G2', 'MAPK3', 'EIF4G1']",0.9999941002753671,0,0,17
206,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3659932873907899,1.1715445003087237,1.1775665743495636,"['PPP1R15A', 'XBP1', 'PPP1R11', 'HSPA5', 'PPP1R9B', 'PPP1CB', 'PPP1CC', 'PPP1R3F', 'MAP1LC3A', 'PPP1R1A', 'DDIT3', 'PPP1R3D', 'PPP1R1B', 'ATF4']",0.9999941002753671,0,0,14
207,Differentiation of white and brown adipocyte WP2895,0.3668899123775416,1.3944620438812625,1.3982179467967972,"['CEBPA', 'CEBPB', 'EBF3', 'PPARG', 'ZNF423']",0.9999941002753671,0,0,5
208,MAPK pathway in congenital thyroid cancer WP4928,0.3668899123775416,1.3944620438812625,1.3982179467967972,"['MAP2K1', 'JUN', 'FOS', 'ELK1', 'MAPK3']",0.9999941002753671,0,0,5
209,Pyrimidine metabolism and related diseases WP4225,0.3668899123775416,1.3944620438812625,1.3982179467967972,"['NT5C', 'RRM2', 'CPS1', 'RRM2B', 'TYMP']",0.9999941002753671,0,0,5
210,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3697337571863974,1.200584002023314,1.1945475947650324,"['NFKBIA', 'BAD', 'DLG4', 'PDE3A', 'NEFL', 'PRKG2', 'CYCS', 'NOS1', 'CALM1', 'CALM2', 'NFKB1']",0.9999941002753671,0,0,11
211,Neovascularisation processes WP4331,0.3714948087847073,1.2550858652575958,1.2428116132011329,"['JAG1', 'NOTCH4', 'PDGFB', 'MAPK1', 'NFKB1', 'TGFBR1', 'RELB', 'MAPK3']",0.9999941002753671,0,0,8
212,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.37443844046597435,1.147637959075608,1.1273567489599012,"['FZD1', 'JUN', 'CTBP2', 'SERPINF1', 'TCF7', 'WNT7A', 'CXXC4', 'DKK2', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'ROR1', 'WNT2', 'EZH2']",0.9999941002753671,0,0,16
213,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.38351808523571546,1.0761092929446685,1.0313092498996606,"['SHC4', 'RAB3A', 'PIK3R2', 'ELK1', 'ACACB', 'PPP2CA', 'GRIP1', 'RPS6KA5', 'MAPK7', 'CFL1', 'RACK1', 'SIRPA', 'MAPK1', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3', 'NSF', 'VAV3', 'EGR1', 'MAP2K1', 'JUN', 'EGR2', 'BDNF', 'PDPK1', 'STAT1', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'EEF2', 'NFKB1', 'VAV2', 'NFKBIA', 'MARCKS', 'CDK5', 'CAMK1', 'CDK5R1']",0.9999941002753671,0,0,39
214,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.38639657320068416,1.4342268974097954,1.3637935135482318,"['RAB27A', 'MYRIP', 'SYTL3', 'EXPH5']",0.9999941002753671,0,0,4
215,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.38639657320068416,1.4342268974097954,1.3637935135482318,"['NFKBIA', 'MAPK1', 'IKBKG', 'NFKB1']",0.9999941002753671,0,0,4
216,RalA downstream regulated genes WP2290,0.38639657320068416,1.4342268974097954,1.3637935135482318,"['EXOC8', 'RAC3', 'RAC1', 'HRAS']",0.9999941002753671,0,0,4
217,Fatty Acid Biosynthesis WP357,0.38918287675955937,1.2550184891706286,1.1843683850068492,"['PECR', 'ACLY', 'ECHS1', 'FASN', 'ACSL5', 'ACACB', 'ACACA']",0.9999941002753671,0,0,7
218,miRNA regulation of p53 pathway in prostate cancer WP3982,0.38918287675955937,1.2550184891706286,1.1843683850068492,"['CASP8', 'ZMAT3', 'EI24', 'PERP', 'SHISA5', 'BAX', 'BBC3']",0.9999941002753671,0,0,7
219,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.38918287675955937,1.2550184891706286,1.1843683850068492,"['FZD1', 'ADAMTS2', 'SERPINF1', 'P3H2', 'PLOD2', 'P4HB', 'PPIB']",0.9999941002753671,0,0,7
220,Androgen receptor signaling pathway WP138,0.3961992628111992,1.0954822837019706,1.0142391324581506,"['CDKN1A', 'DAXX', 'JUN', 'LIMK2', 'NCOA4', 'DSTN', 'RNF6', 'PIK3R2', 'PARK7', 'ETV5', 'RHOB', 'KAT2B', 'AR', 'SUMO1', 'KAT5', 'PRDX1', 'BAG1', 'RACK1', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN', 'RAD9A']",0.9999941002753671,0,0,24
221,Prion disease pathway WP3995,0.4026594012985858,1.1889673973517303,1.0815611149211262,"['PRNP', 'HSPA5', 'RAD21', 'RFX5', 'MAPK1', 'ELK1', 'NFKB1', 'HSP90B1', 'MAPK3']",0.9999941002753671,0,0,9
222,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4029089405397947,1.133633236305901,1.0305232813108067,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'JUND', 'HSPA5', 'HSPB1', 'NRG1', 'TRAF1', 'RNF7', 'NFKB1', 'ABL1', 'MAPK1', 'IER3']",0.9999941002753671,0,0,14
223,Breast cancer pathway WP4262,0.408642045189101,1.0711477443942214,0.9585869348521242,"['SHC4', 'CDKN1A', 'NOTCH4', 'TCF7', 'PIK3R2', 'FGF1', 'DLL1', 'IGF1R', 'DLL3', 'FRAT1', 'FGF7', 'FRAT2', 'HEY1', 'E2F1', 'MAPK1', 'WNT2', 'HRAS', 'FGF22', 'SKP1', 'MAPK3', 'FZD1', 'MAP2K1', 'JUN', 'GADD45B', 'GADD45A', 'WNT7A', 'FOS', 'FGF17', 'SFRP4', 'CSNK2B', 'BAX', 'FGF10']",0.9999941002753671,0,0,32
224,Heart Development WP1591,0.4092741652321792,1.2549511486664906,1.121135728854634,"['HEY1', 'BHLHE40', 'NFATC3', 'MAPK1', 'NFATC2', 'FGF10']",0.9999941002753671,0,0,6
225,Immune response to tuberculosis WP4197,0.4092741652321792,1.2549511486664906,1.121135728854634,"['IFNAR2', 'STAT1', 'TAP1', 'IFIT1', 'JAK2', 'IFIT3']",0.9999941002753671,0,0,6
226,miRNAs involvement in the immune response in sepsis WP4329,0.4092741652321792,1.2549511486664906,1.121135728854634,"['NFKBIA', 'IRAK1', 'TRAF3', 'IKBKG', 'NFKB1', 'RELB']",0.9999941002753671,0,0,6
227,Nucleotide metabolism WP404,0.4092741652321792,1.2549511486664906,1.121135728854634,"['PRPS1', 'RRM2', 'RRM2B', 'NME2', 'OAZ1', 'SRM']",0.9999941002753671,0,0,6
228,Ovarian infertility WP34,0.4092741652321792,1.2549511486664906,1.121135728854634,"['EGR1', 'CEBPB', 'CDKN1B', 'SMPD1', 'FSHR', 'INHA']",0.9999941002753671,0,0,6
229,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4092741652321792,1.2549511486664906,1.121135728854634,"['MAP2K1', 'HTR2B', 'MAPK1', 'ELK1', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,6
230,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4092741652321792,1.2549511486664906,1.121135728854634,"['EGR1', 'MAP2K1', 'RPS6KA5', 'MAPK1', 'ELK1', 'MAPK3']",0.9999941002753671,0,0,6
231,Biomarkers for urea cycle disorders WP4583,0.40995032156177486,1.5058575197889181,1.3428022037294978,"['GATM', 'GOT1', 'GPT']",0.9999941002753671,0,0,3
232,Leptin and adiponectin WP3934,0.40995032156177486,1.5058575197889181,1.3428022037294978,"['LEPR', 'ADIPOR1', 'ACACA']",0.9999941002753671,0,0,3
233,Trans-sulfuration pathway WP2333,0.40995032156177486,1.5058575197889181,1.3428022037294978,"['AHCY', 'GOT1', 'MAT2B']",0.9999941002753671,0,0,3
234,MAPK Signaling Pathway WP382,0.4103046853967528,1.0476900407384935,0.9333401838069615,"['HSPB1', 'FGF1', 'ELK1', 'FGF7', 'RPS6KA5', 'STMN1', 'RAC3', 'MAP3K8', 'RAC1', 'IKBKG', 'HRAS', 'PRKCG', 'DUSP4', 'DAXX', 'DUSP2', 'MAP2K1', 'DUSP3', 'DUSP1', 'PRKCD', 'CACNA2D3', 'FOS', 'MAPK8IP2', 'DUSP6', 'TGFBR1', 'MAPK8IP1', 'DUSP7', 'TNFRSF1A', 'CACNB1', 'CACNB3', 'DDIT3', 'ATF4', 'PDGFB', 'CACNA1A', 'CACNA1C', 'RELB', 'RASGRP3', 'MAPK7', 'MAPK1', 'FLNB', 'CACNG2', 'FGF22', 'MAPK3', 'HSPA8', 'JUN', 'JUND', 'HSPA1L', 'GADD45A', 'BDNF', 'NFATC3', 'NFKB1', 'FGF17', 'NR4A1', 'FGF14', 'LAMTOR3', 'FGF12', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9999941002753671,0,0,58
235,Head and Neck Squamous Cell Carcinoma WP4674,0.41370778267062674,1.1020384429009853,0.9726540529860793,"['CDKN1A', 'MAML1', 'PDPK1', 'CDKN2A', 'RPS6', 'GAB1', 'KEAP1', 'PIK3R2', 'NFKB1', 'IGF1R', 'RPTOR', 'FKBP1A', 'CASP8', 'TRAF3', 'DDIT4', 'E2F1', 'FADD', 'HRAS']",0.9999941002753671,0,0,18
236,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.41370778267062674,1.1020384429009853,0.9726540529860793,"['FZD1', 'JUN', 'CTBP2', 'SERPINF1', 'TCF7', 'WNT7A', 'CXXC4', 'DKK2', 'SFRP4', 'CDK8', 'FRAT1', 'FRAT2', 'SFRP2', 'HNRNPK', 'CSNK2B', 'ROR1', 'WNT2', 'EZH2']",0.9999941002753671,0,0,18
237,Glycosylation and related congenital defects WP4521,0.42178638849909017,1.1811329551635714,1.0196204428239333,"['GMPPB', 'DPM2', 'DPM3', 'MPI', 'PMM2', 'DOLK', 'MGAT2', 'MPDU1']",0.9999941002753671,0,0,8
238,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.42990004909841556,1.140869439838512,0.9631248803700777,"['RPTOR', 'MAP1LC3A', 'EIF2B2', 'IGFBP5', 'AKT1S1', 'TNFSF9', 'PLD1', 'NFKB1', 'IGF1R', 'TNFRSF1A']",0.9999941002753671,0,0,10
239,ERK Pathway in Huntington's Disease WP3853,0.4326413380441515,1.2548838437170011,1.051399675999581,"['RPS6KA5', 'BDNF', 'MAPK1', 'ELK1', 'HRAS']",0.9999941002753671,0,0,5
240,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['PPARG', 'CYP2C18']",0.9999941002753671,0,0,2
241,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['CDKN1A', 'ABCB1']",0.9999941002753671,0,0,2
242,Metabolism of alpha-linolenic acid WP4586,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['ALOX12', 'PTGS2']",0.9999941002753671,0,0,2
243,Mitochondrial fatty acid synthesis pathway WP4317,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['MCAT', 'ACACA']",0.9999941002753671,0,0,2
244,PTF1A related regulatory pathway WP4147,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['KAT2B', 'FGF10']",0.9999941002753671,0,0,2
245,SARS-CoV-2 and COVID-19 Pathway WP4846,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['NRP1', 'FURIN']",0.9999941002753671,0,0,2
246,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['MAPK1', 'MAPK3']",0.9999941002753671,0,0,2
247,Vitamin D Metabolism WP1531,0.4406643624041603,1.6730853776488175,1.3710462463062743,"['RXRB', 'DHCR7']",0.9999941002753671,0,0,2
248,7-oxo-C and 7beta-HC pathways WP5064,0.4432977142235788,1.1712273287550625,0.9528094701656619,"['HSD11B1', 'HSD11B2', 'DBP', 'ACOT11', 'DHCR7', 'ACOT6', 'ACOT4']",0.9999941002753671,0,0,7
249,DNA Mismatch Repair WP531,0.4432977142235788,1.1712273287550625,0.9528094701656619,"['POLE4', 'POLD4', 'PCNA', 'RPA3', 'POLE2', 'POLD2', 'POLE3']",0.9999941002753671,0,0,7
250,Physiological and pathological hypertrophy of the heart WP1528,0.4432977142235788,1.1712273287550625,0.9528094701656619,"['JUN', 'MAPK1', 'RAC1', 'FOS', 'IL6ST', 'CALM1', 'CALM2']",0.9999941002753671,0,0,7
251,Unfolded protein response WP4925,0.4432977142235788,1.1712273287550625,0.9528094701656619,"['PPP1R15A', 'XBP1', 'CASP8', 'HSPA5', 'DDIT3', 'BBC3', 'ATF4']",0.9999941002753671,0,0,7
252,Circadian rhythm related genes WP3594,0.45043577703609405,1.0378435897435898,0.8277215393074905,"['MAGEL2', 'AHCY', 'CHRM1', 'SUV39H1', 'CIPC', 'BHLHE41', 'OPRL1', 'RBM4B', 'CCAR2', 'RELB', 'PPP1CB', 'HEBP1', 'PPP1CC', 'DBP', 'NFIL3', 'UBC', 'PRKG2', 'RPS27A', 'SKP1', 'PRKCG', 'CHRNB2', 'KLF10', 'EGR1', 'JUN', 'EGR3', 'JUND', 'USP2', 'NR1D2', 'CARTPT', 'HCRTR2', 'NR2F6', 'PER2', 'STAR', 'ADORA2A', 'ID2', 'BHLHE40', 'KLF9', 'PPARG', 'GHRL', 'ATF5', 'UBA52', 'ATF4', 'EZH2']",0.9999941002753671,0,0,43
253,Ciliary landscape WP4352,0.4546971873771879,1.0293508234097946,0.8112556805586847,"['DOCK5', 'GDI1', 'ZMYND19', 'MYL6B', 'RPGR', 'PSMD8', 'PSMD7', 'APMAP', 'ARHGDIA', 'NEFL', 'BBS9', 'NEFM', 'TMED1', 'RAC1', 'NINL', 'RAB8A', 'NUDC', 'EXOC8', 'IFT140', 'DYNLT3', 'DYNLL1', 'DYNLL2', 'TBC1D4', 'ERF', 'MCM3', 'CD2BP2', 'ANKS6', 'MCM4', 'ARL8B', 'ECHS1', 'CTBP2', 'SSNA1', 'VPS4A', 'HTRA2', 'COPS7A', 'PGRMC2', 'EXOSC4', 'DCAF11', 'NDUFA5', 'RHBDD2', 'H3F3A', 'COX6C', 'LSM4', 'NFKB1', 'COPS3', 'EHD3', 'COPS6', 'RAB14', 'TTC30A', 'GID8', 'RANBP10', 'DYNLRB1', 'CALM1', 'YPEL5', 'COPS8', 'CALM2', 'GLA']",0.9999941002753671,0,0,57
254,Cell Differentiation - Index expanded WP2023,0.4607785095776752,1.254816574294009,0.9722793237290422,"['PAX7', 'ID2', 'MEF2D', 'EZH2']",0.9999941002753671,0,0,4
255,Overview of nanoparticle effects WP3287,0.4607785095776752,1.254816574294009,0.9722793237290422,"['LAMA3', 'FN1', 'BAX', 'PTGS2']",0.9999941002753671,0,0,4
256,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4607785095776752,1.254816574294009,0.9722793237290422,"['CDH6', 'FN1', 'MAPK1', 'MAPK3']",0.9999941002753671,0,0,4
257,Endometrial cancer WP4155,0.46165613140978,1.0666644597457626,0.8244622614898798,"['CDKN1A', 'MAP2K1', 'GADD45B', 'PDPK1', 'BAD', 'GADD45A', 'TCF7', 'PIK3R2', 'FOS', 'FGF1', 'ELK1', 'MAPK1', 'BAX', 'CTNNA3', 'CTNNA2', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,17
258,T-cell receptor (TCR) signaling pathway WP69,0.4632343154973479,1.0596949891067537,0.8154588955638065,"['VAV3', 'IL15RA', 'MAP2K1', 'JUN', 'CD83', 'PDPK1', 'PRKCD', 'NFATC2', 'PIK3R2', 'FOS', 'GAB2', 'NFKB1', 'NFKBIA', 'MAPK1', 'MAP3K8', 'PRKCQ', 'IKBKG', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,19
259,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.4679145130758729,1.1582945704942007,0.8796895884022975,"['CBX5', 'H3F3B', 'SUV39H1', 'H3F3A', 'E2F1', 'INPP5K']",0.9999941002753671,0,0,6
260,Gastric Cancer Network 1 WP2361,0.4679145130758729,1.1582945704942007,0.8796895884022975,"['CCNA1', 'H3F3A', 'ACTL6A', 'MCM4', 'GATD3B', 'GATD3A']",0.9999941002753671,0,0,6
261,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.4679145130758729,1.1582945704942007,0.8796895884022975,"['FZD1', 'PDGFRA', 'EDA', 'PTCH1', 'FGF1', 'NFKB1']",0.9999941002753671,0,0,6
262,Development of ureteric collection system WP5053,0.4717351618059012,1.1153970350799942,0.8380396742085908,"['GRIP1', 'FRAS1', 'GREB1L', 'RARB', 'GFRA1', 'SPRY1', 'FAT4', 'ETV4']",0.9999941002753671,0,0,8
263,Type 2 papillary renal cell carcinoma WP4241,0.4741485627636671,1.0911514900757393,0.81425497701401,"['CDKN1A', 'EGLN3', 'EGLN2', 'EPAS1', 'PDGFB', 'SLC2A1', 'TFEB', 'COL21A1', 'ELOB', 'ELOC']",0.9999941002753671,0,0,10
264,Kit receptor signaling pathway WP304,0.47703704204546643,1.0647036653916782,0.7880522732329908,"['MAP2K1', 'STAT1', 'BAD', 'RPS6', 'MITF', 'PIK3R2', 'FOS', 'GAB2', 'TEC', 'MAPK1', 'JAK2', 'JUNB', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,14
265,p53 transcriptional gene network WP4963,0.47703704204546643,1.0647036653916782,0.7880522732329908,"['BTG2', 'CDKN1A', 'SIVA1', 'MGMT', 'GADD45A', 'SLC2A1', 'ISG15', 'CX3CL1', 'BBC3', 'DRAM1', 'RRM2B', 'ZMAT3', 'PERP', 'BAX']",0.9999941002753671,0,0,14
266,COVID-19 adverse outcome pathway WP4891,0.4887523055787919,2.509493670886076,1.7965451397619088,['IL7'],0.9999941002753671,0,0,1
267,SCFA and skeletal muscle substrate metabolism WP4030,0.4887523055787919,2.509493670886076,1.7965451397619088,['PYY'],0.9999941002753671,0,0,1
268,Thyroxine (Thyroid Hormone) Production WP1981,0.4887523055787919,2.509493670886076,1.7965451397619088,['TSHR'],0.9999941002753671,0,0,1
269,Common Pathways Underlying Drug Addiction WP2636,0.495863403330918,1.0617194809421144,0.7447482120352793,"['PPP1CB', 'PRKCG', 'PPP1CC', 'MAP2K1', 'PPP1R1A', 'MAPK1', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999941002753671,0,0,11
270,One-carbon metabolism and related pathways WP3940,0.495863403330918,1.0617194809421144,0.7447482120352793,"['DMGDH', 'PCYT2', 'GPX4', 'GPX3', 'SHMT2', 'ETNK2', 'CHDH', 'DNMT3A', 'PLD1', 'SOD2', 'SOD1']",0.9999941002753671,0,0,11
271,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4965767968400024,1.2547493403693932,0.878346033423685,"['MAP2K1', 'PRKCQ', 'MAFK']",0.9999941002753671,0,0,3
272,Genes targeted by miRNAs in adipocytes WP1992,0.4965767968400024,1.2547493403693932,0.878346033423685,"['TMSB4X', 'KCNQ1', 'KCNJ2']",0.9999941002753671,0,0,3
273,Glutathione metabolism WP100,0.4965767968400024,1.2547493403693932,0.878346033423685,"['G6PD', 'GPX4', 'GPX3']",0.9999941002753671,0,0,3
274,Neuroinflammation WP4919,0.4965767968400024,1.2547493403693932,0.878346033423685,"['NFKBIA', 'JUN', 'FOS']",0.9999941002753671,0,0,3
275,Thiamine metabolic pathways WP4297,0.4965767968400024,1.2547493403693932,0.878346033423685,"['BCKDK', 'SLC19A3', 'TKT']",0.9999941002753671,0,0,3
276,Microglia Pathogen Phagocytosis Pathway WP3937,0.4967562263085834,1.1406834981280598,0.7980858979086364,"['VAV3', 'RAC3', 'PIK3R2', 'RAC1', 'VAV2']",0.9999941002753671,0,0,5
277,Pregnane X receptor pathway WP2876,0.4967562263085834,1.1406834981280598,0.7980858979086364,"['HSP90AA1', 'PSMC5', 'ABCB1', 'CYP3A5', 'CYP3A7']",0.9999941002753671,0,0,5
278,Osteoblast differentiation WP4787,0.5079241900372791,1.020780587396738,0.6915003241593787,"['PRKCG', 'FZD1', 'PRKCH', 'JAG1', 'STAT1', 'NOTCH4', 'PTCH1', 'PRKCD', 'WNT7A', 'PIK3R2', 'PIK3C2G', 'FGF1', 'DLL1', 'DLL3', 'FGF7', 'MAPK7', 'HEY1', 'MAPK1', 'PRKCQ', 'PPARG', 'PRKD1', 'WNT2', 'FGF10', 'MAPK3']",0.9999941002753671,0,0,24
279,DNA damage response WP707,0.5121284739162698,1.0294970231427738,0.6889185706630223,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'BBC3', 'CCNB1', 'CASP8', 'RRM2B', 'CCNE2', 'CDK5', 'E2F1', 'ABL1', 'CYCS', 'BAX', 'RAD9A']",0.9999941002753671,0,0,16
280,Notch Signaling Pathway Netpath WP61,0.5136154153235006,1.0332798904160765,0.6884542552499253,"['PSENEN', 'CDKN1A', 'JAG1', 'MAML2', 'MAML1', 'NOTCH4', 'PIK3R2', 'DLL1', 'NFKB1', 'DLL3', 'APH1A', 'HEY1', 'JAK2', 'SKP1']",0.9999941002753671,0,0,14
281,Cytosolic DNA-sensing pathway WP4655,0.5154098109912969,1.0383678829720289,0.6882229074199878,"['NFKBIA', 'CASP8', 'IL18', 'POLR2E', 'ISG15', 'POLR3H', 'IKBKG', 'FADD', 'POLR3K', 'POLR2K', 'NFKB1', 'POLR2L']",0.9999941002753671,0,0,12
282,ATM Signaling Pathway WP2516,0.5176547119742864,1.0455767027931977,0.6884566740346686,"['NFKBIA', 'CDKN1A', 'CCNB1', 'JUN', 'CRADD', 'GADD45A', 'H2AFX', 'ABL1', 'IKBKG', 'RAD9A']",0.9999941002753671,0,0,10
283,DNA Replication WP466,0.5176547119742864,1.0455767027931977,0.6884566740346686,"['POLD4', 'PCNA', 'PRIM1', 'RPA3', 'POLE2', 'UBC', 'POLD2', 'MCM3', 'MCM4', 'UBA52']",0.9999941002753671,0,0,10
284,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5206109282195416,1.0565806855315303,0.689685467392804,"['IFNAR2', 'NFKBIA', 'JUN', 'STAT1', 'TRAF3', 'IKBKG', 'FOS', 'NFKB1']",0.9999941002753671,0,0,8
285,Prostaglandin Synthesis and Regulation WP98,0.5206109282195416,1.0565806855315303,0.689685467392804,"['HSD11B1', 'HSD11B2', 'CBR1', 'S100A6', 'MITF', 'PPARG', 'PTGS2', 'PTGES']",0.9999941002753671,0,0,8
286,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5206109282195416,1.0565806855315303,0.689685467392804,"['ACTA2', 'CASP8', 'MAPK1', 'BAX', 'PRKCQ', 'NOS1', 'TGFBR1', 'TNFRSF1A']",0.9999941002753671,0,0,8
287,EPO Receptor Signaling WP581,0.5248221896781988,1.0754460749179524,0.6933355246995744,"['MAP2K1', 'STAT1', 'MAPK1', 'JAK2', 'EPOR', 'MAPK3']",0.9999941002753671,0,0,6
288,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5248221896781988,1.0754460749179524,0.6933355246995744,"['CEBPA', 'TTC9', 'CEBPB', 'PNCK', 'ERBB4', 'JAK2']",0.9999941002753671,0,0,6
289,Signal Transduction of S1P Receptor WP26,0.5248221896781988,1.0754460749179524,0.6933355246995744,"['SMPD2', 'ASAH1', 'MAPK7', 'MAPK1', 'PLCB2', 'MAPK3']",0.9999941002753671,0,0,6
290,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.5248221896781988,1.0754460749179524,0.6933355246995744,"['NFKBIA', 'GSK3A', 'NFATC2', 'CALM1', 'CALM2', 'NFKB1']",0.9999941002753671,0,0,6
291,Leptin signaling pathway WP2034,0.5257928065106939,1.014387353561321,0.652096929967189,"['GSK3A', 'MAP2K1', 'STAT1', 'BAD', 'RPS6', 'PIK3R2', 'ELK1', 'ACACB', 'ACACA', 'NFKB1', 'CFL2', 'LEPR', 'MAPK1', 'BAX', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,19
292,BMP Signaling Pathway in Eyelid Development WP3927,0.5316962209629384,1.1152752118706197,0.7045003536940845,"['JUN', 'DKK2', 'MAPK3', 'FGF10']",0.9999941002753671,0,0,4
293,Fatty acid transporters WP5061,0.5316962209629384,1.1152752118706197,0.7045003536940845,"['FABP5', 'FABP6', 'FABP7', 'ACSL5']",0.9999941002753671,0,0,4
294,"GPCRs, Class B Secretin-like WP334",0.5316962209629384,1.1152752118706197,0.7045003536940845,"['CALCRL', 'ADGRG2', 'GLP2R', 'PTH1R']",0.9999941002753671,0,0,4
295,Retinoblastoma gene in cancer WP2446,0.5398575138737802,1.0036575669228731,0.6187047447050775,"['PLK4', 'CDKN1A', 'CDKN1B', 'PCNA', 'RRM2', 'H2AFZ', 'SUV39H1', 'PRIM1', 'DCK', 'SMC2', 'CCNB1', 'CCNE2', 'TFDP2', 'RPA3', 'POLE2', 'STMN1', 'MCM3', 'E2F1', 'ABL1', 'MCM4']",0.9999941002753671,0,0,20
296,IL-2 signaling pathway WP49,0.541498538862579,1.0265111474149529,0.6296772439877775,"['MAP2K1', 'JUN', 'STAT1', 'RPS6', 'MAPK1', 'FOS', 'GAB2', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,9
297,ACE Inhibitor Pathway WP554,0.5468261756598425,1.254682141915062,0.7573566354693457,"['MAS1', 'ATP6AP2']",0.9999941002753671,0,0,2
298,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5468261756598425,1.254682141915062,0.7573566354693457,"['TBC1D4', 'RPS6']",0.9999941002753671,0,0,2
299,Insulin signaling in adipocytes (normal condition) WP3634,0.5468261756598425,1.254682141915062,0.7573566354693457,"['TBC1D4', 'RPS6']",0.9999941002753671,0,0,2
300,LDLRAD4 and what we know about it WP4904,0.5468261756598425,1.254682141915062,0.7573566354693457,"['PMEPA1', 'TGFBR1']",0.9999941002753671,0,0,2
301,Nephrogenesis WP5052,0.5468261756598425,1.254682141915062,0.7573566354693457,"['JAG1', 'GREB1L']",0.9999941002753671,0,0,2
302,Serotonin Transporter Activity WP1455,0.5468261756598425,1.254682141915062,0.7573566354693457,"['PPP2CB', 'NOS1']",0.9999941002753671,0,0,2
303,Tamoxifen metabolism WP691,0.5468261756598425,1.254682141915062,0.7573566354693457,"['CYP1B1', 'CYP3A5']",0.9999941002753671,0,0,2
304,Cell migration and invasion through p75NTR WP4561,0.5479803361574132,1.033218358658836,0.6214972456971005,"['EFNA1', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'RAC1']",0.9999941002753671,0,0,7
305,Eukaryotic Transcription Initiation WP405,0.5541014628861466,1.0036498280878074,0.5925623487418695,"['TAF13', 'POLR2C', 'TAF9', 'POLR2E', 'POLR1E', 'TAF7', 'POLR3H', 'TAF6', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999941002753671,0,0,12
306,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5541014628861466,1.0036498280878074,0.5925623487418695,"['KAT2B', 'CEBPA', 'CDKN1A', 'CEBPB', 'ICMT', 'TCF7', 'LMNA', 'E2F1', 'PPARG', 'JUNB', 'EMD', 'ACTB']",0.9999941002753671,0,0,12
307,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5578841623035768,1.0455165434706089,0.6101675663568997,"['ANGPT2', 'MAPK1', 'LTBP1', 'TGFBR1', 'MAPK3']",0.9999941002753671,0,0,5
308,Purinergic signaling WP4900,0.5578841623035768,1.0455165434706089,0.6101675663568997,"['P2RY12', 'GNAZ', 'ADORA2A', 'LPAR6', 'P2RY14']",0.9999941002753671,0,0,5
309,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5599630307582503,1.0036478984932593,0.5819998737799007,"['DAXX', 'JUN', 'CASP8', 'CASP6', 'LMNA', 'HSPB1', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9999941002753671,0,0,10
310,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5599630307582503,1.0036478984932593,0.5819998737799007,"['CDKN1A', 'UCHL1', 'JUN', 'RRM2', 'RAC1', 'PTGS2', 'TGFBR1', 'NFKB1', 'VAV2', 'MAPK3']",0.9999941002753671,0,0,10
311,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5677915124265257,1.0036459709379129,0.5680646063651641,"['HEXIM1', 'NFKBIA', 'SUPT4H1', 'NFATC3', 'NFATC2', 'NELFB', 'SUPT5H', 'NFKB1']",0.9999941002753671,0,0,8
312,PDGFR-beta pathway WP3972,0.5677915124265257,1.0036459709379129,0.5680646063651641,"['MAP2K1', 'JUN', 'STAT1', 'FOS', 'JAK2', 'ELK1', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,8
313,Corticotropin-releasing hormone signaling pathway WP2355,0.5693921451767574,0.9838740691081628,0.5541040022570798,"['GNAZ', 'HSP90AA1', 'MAP2K1', 'JUND', 'PRKCD', 'IL18', 'FOS', 'ELK1', 'ACACA', 'NFKB1', 'FOSL2', 'NFKBIA', 'NR4A1', 'STAR', 'GNB2', 'MAPK1', 'FOSB', 'PRKCQ', 'JUNB', 'MAPK3']",0.9999941002753671,0,0,20
314,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5736009430667254,0.9817333717247336,0.5456683636718119,"['CDKN1A', 'MAP2K1', 'JUN', 'GADD45B', 'DCC', 'BAD', 'GADD45A', 'TCF7', 'FOS', 'PTGS2', 'TGFBR1', 'BBC3', 'RAC3', 'MAPK1', 'CYCS', 'BAX', 'RAC1', 'MAPK3']",0.9999941002753671,0,0,18
315,Alanine and aspartate metabolism WP106,0.5762178432730868,1.0753863550697325,0.5928276871455437,"['GOT1', 'GOT2', 'GPT']",0.9999941002753671,0,0,3
316,Dopaminergic Neurogenesis WP2855,0.5762178432730868,1.0753863550697325,0.5928276871455437,"['NEUROD1', 'ALDH1A1', 'SLC18A2']",0.9999941002753671,0,0,3
317,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.5762178432730868,1.0753863550697325,0.5928276871455437,"['GRM2', 'GABBR1', 'GRM4']",0.9999941002753671,0,0,3
318,ID signaling pathway WP53,0.5762178432730868,1.0753863550697325,0.5928276871455437,"['RBL1', 'ID2', 'ELK1']",0.9999941002753671,0,0,3
319,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.5762178432730868,1.0753863550697325,0.5928276871455437,"['IDI1', 'HMGCS1', 'PMVK']",0.9999941002753671,0,0,3
320,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5765345389729747,0.9856746241595528,0.5428307581728102,"['ACAN', 'THRA', 'HMGCS1', 'STAT1', 'PTCH1', 'TIMP3', 'PTH1R', 'CALM1', 'SLC38A2', 'CALM2', 'IGF1R']",0.9999941002753671,0,0,11
321,Endochondral Ossification WP474,0.5765345389729747,0.9856746241595528,0.5428307581728102,"['ACAN', 'THRA', 'HMGCS1', 'STAT1', 'PTCH1', 'TIMP3', 'PTH1R', 'CALM1', 'SLC38A2', 'CALM2', 'IGF1R']",0.9999941002753671,0,0,11
322,miRNA regulation of DNA damage response WP1530,0.5785231539937945,0.9790710139031493,0.5358227623266157,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'BBC3', 'CCNB1', 'CASP8', 'RRM2B', 'CCNE2', 'CDK5', 'E2F1', 'ABL1', 'CYCS', 'BAX', 'RAD9A']",0.9999941002753671,0,0,16
323,Cardiac Progenitor Differentiation WP2406,0.5790778815016886,1.0036440454185371,0.5483091087877424,"['MESP1', 'PDGFRA', 'ACTC1', 'SIRPA', 'NRG1', 'THY1']",0.9999941002753671,0,0,6
324,White fat cell differentiation WP4149,0.5790778815016886,1.0036440454185371,0.5483091087877424,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG', 'ZNF423']",0.9999941002753671,0,0,6
325,Pancreatic adenocarcinoma pathway WP4263,0.5933560169584803,0.9682386820937254,0.505382534720834,"['CDKN1A', 'MAP2K1', 'GADD45B', 'CDKN2A', 'STAT1', 'BAD', 'GADD45A', 'PRKCD', 'PEBP1', 'PIK3R2', 'PLD1', 'TGFBR1', 'DUSP6', 'NFKB1', 'E2F1', 'RAC3', 'MAPK1', 'BAX', 'RAC1', 'IKBKG', 'ARHGEF6', 'MAPK3']",0.9999941002753671,0,0,22
326,Eicosanoid Synthesis WP167,0.597618698629107,1.003642121931908,0.5166773290648291,"['PTGES2', 'ALOX12', 'PTGS2', 'PTGES']",0.9999941002753671,0,0,4
327,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.597618698629107,1.003642121931908,0.5166773290648291,"['GSK3A', 'BAX', 'BCL2L14', 'BCL2L2']",0.9999941002753671,0,0,4
328,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.597618698629107,1.003642121931908,0.5166773290648291,"['NFKBIA', 'IKBKG', 'NFKBIE', 'NFKB1']",0.9999941002753671,0,0,4
329,Glioblastoma signaling pathways WP2261,0.6095315466735455,0.9577846331823002,0.47416524056454346,"['PRKCG', 'PDGFRA', 'CDKN1A', 'MAP2K1', 'CDKN1B', 'PRKCH', 'CDKN2C', 'PDPK1', 'CDKN2A', 'PRKCD', 'GAB1', 'PIK3C2G', 'PIK3R2', 'FOXO4', 'IGF1R', 'E2F1', 'MAPK1', 'SPRY2', 'PRKCQ', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,21
330,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6150418128252336,0.9649906587604581,0.4690482088228198,"['JUN', 'SRXN1', 'GSTP1', 'KEAP1', 'FOS']",0.9999941002753671,0,0,5
331,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6150418128252336,0.9649906587604581,0.4690482088228198,"['PTGES2', 'MAPK1', 'PTGS2', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,5
332,AGE/RAGE pathway WP2324,0.6181268814395225,0.9492000600759531,0.45662363585764715,"['MAP2K1', 'JUN', 'STAT1', 'PRKCD', 'FOXO4', 'NFKB1', 'SOD1', 'NFKBIA', 'CASP8', 'MAPK1', 'CYCS', 'RAC1', 'JAK2', 'MAPK3']",0.9999941002753671,0,0,14
333,Notch Signaling WP268,0.6267995567667584,0.9407703488372093,0.4394606189769596,"['APH1A', 'KAT2B', 'JAG1', 'CTBP2', 'MAML1', 'NOTCH4', 'INPP5K', 'DLL1', 'DLL3']",0.9999941002753671,0,0,9
334,Non-small cell lung cancer WP4255,0.6330842394015551,0.9406291390728477,0.4300102909556592,"['PRKCG', 'CDKN1A', 'MAP2K1', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PIK3R2', 'FHIT', 'RXRB', 'CASP8', 'E2F1', 'RARB', 'MAPK1', 'CYCS', 'BAX', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,18
335,Gene regulatory network modelling somitogenesis  WP2854,0.6344660836631374,1.2546149789029535,0.5708139922538761,['DLL1'],0.9999941002753671,0,0,1
336,let-7 inhibition of ES cell reprogramming WP3299,0.6344660836631374,1.2546149789029535,0.5708139922538761,['EGR1'],0.9999941002753671,0,0,1
337,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.6344660836631374,1.2546149789029535,0.5708139922538761,['MAS1'],0.9999941002753671,0,0,1
338,Tgif disruption of Shh signaling WP3674,0.6344660836631374,1.2546149789029535,0.5708139922538761,['FOXG1'],0.9999941002753671,0,0,1
339,Aspirin and miRNAs WP4707,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['PTGS2', 'NFKB1']",0.9999941002753671,0,0,2
340,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['DHCR24', 'DHCR7']",0.9999941002753671,0,0,2
341,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['BATF3', 'ID2']",0.9999941002753671,0,0,2
342,Inflammatory Response Pathway WP453,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['FN1', 'TNFRSF1A']",0.9999941002753671,0,0,2
343,Liver X receptor pathway WP2874,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['ABCG8', 'FASN']",0.9999941002753671,0,0,2
344,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['NRG3', 'ERBB4']",0.9999941002753671,0,0,2
345,Mevalonate pathway WP3963,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['HMGCS1', 'PMVK']",0.9999941002753671,0,0,2
346,Pentose Phosphate Metabolism WP134,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['G6PD', 'TKT']",0.9999941002753671,0,0,2
347,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['ELK1', 'MEF2D']",0.9999941002753671,0,0,2
348,Sulfation Biotransformation Reaction WP692,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['G6PD', 'SULT4A1']",0.9999941002753671,0,0,2
349,Urea cycle and related diseases WP4571,0.6379191241089566,1.0036402004748088,0.4511801978313257,"['SLC25A15', 'CPS1']",0.9999941002753671,0,0,2
350,Oxysterols derived from cholesterol WP4545,0.6432264303701247,0.9242639085828677,0.40783927814817855,"['CYP39A1', 'DBP', 'INSIG1', 'ACOT11', 'DHCR7', 'ACOT6', 'ACOT4']",0.9999941002753671,0,0,7
351,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6432264303701247,0.9242639085828677,0.40783927814817855,"['RPTOR', 'CDKN1B', 'BAD', 'TFEB', 'PIK3R2', 'FOXO4', 'HRAS']",0.9999941002753671,0,0,7
352,The influence of laminopathies on Wnt signaling WP4844,0.6432264303701247,0.9242639085828677,0.40783927814817855,"['CEBPA', 'CEBPB', 'ICMT', 'TCF7', 'LMNA', 'PPARG', 'EMD']",0.9999941002753671,0,0,7
353,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6474007593522703,0.9408641160949868,0.4090780875243281,"['CDKN1A', 'ROS1', 'NFKB1']",0.9999941002753671,0,0,3
354,GDNF/RET signaling axis WP4830,0.6474007593522703,0.9408641160949868,0.4090780875243281,"['GFRA1', 'SPRY1', 'FAT4']",0.9999941002753671,0,0,3
355,Leptin Insulin Overlap WP3935,0.6474007593522703,0.9408641160949868,0.4090780875243281,"['PDPK1', 'LEPR', 'JAK2']",0.9999941002753671,0,0,3
356,"NAD metabolism, sirtuins and aging WP3630",0.6474007593522703,0.9408641160949868,0.4090780875243281,"['PPARG', 'ROS1', 'NFKB1']",0.9999941002753671,0,0,3
357,ATM Signaling Network in Development and Disease  WP3878,0.6511580163756433,0.919769081614666,0.3945836378709624,"['PTPA', 'G6PD', 'KAT5', 'ATMIN', 'CDK5', 'H2AFX', 'HSPB1', 'IKBKG', 'NFKB1', 'HMGN1', 'CDK5R1']",0.9999941002753671,0,0,11
358,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6511580163756433,0.919769081614666,0.3945836378709624,"['PDGFRA', 'CDKN1A', 'FGF7', 'HSP90AA1', 'JUN', 'CDKN2A', 'BAX', 'FOS', 'ELK1', 'JUNB', 'TNFRSF1A']",0.9999941002753671,0,0,11
359,Glycosaminoglycan degradation WP4815,0.6576104154779199,0.9123059574365988,0.38238628802450053,"['HYAL2', 'IDS', 'ARSB', 'SGSH']",0.9999941002753671,0,0,4
360,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6576104154779199,0.9123059574365988,0.38238628802450053,"['JUN', 'MAPK1', 'PRKCQ', 'MAPK3']",0.9999941002753671,0,0,4
361,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6576104154779199,0.9123059574365988,0.38238628802450053,"['FGF7', 'SUV39H1', 'CDC37', 'FN1']",0.9999941002753671,0,0,4
362,Angiogenesis WP1539,0.6675872325867827,0.8959684718660431,0.362047609651187,"['PDGFRA', 'PDGFB', 'TIMP2', 'MAPK1', 'TIMP3']",0.9999941002753671,0,0,5
363,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6675872325867827,0.8959684718660431,0.362047609651187,"['CASP8', 'BAD', 'BAX', 'FADD', 'BBC3']",0.9999941002753671,0,0,5
364,Striated Muscle Contraction Pathway WP383,0.6675872325867827,0.8959684718660431,0.362047609651187,"['ACTA2', 'MYOM1', 'MYBPC1', 'ACTC1', 'ACTG1']",0.9999941002753671,0,0,5
365,TLR4 Signaling and Tolerance WP3851,0.6675872325867827,0.8959684718660431,0.362047609651187,"['NFKBIA', 'IRAK1', 'TRAF3', 'IKBKG', 'NFKB1']",0.9999941002753671,0,0,5
366,TGF-beta Receptor Signaling WP560,0.6761900269762373,0.8958309731505608,0.35052176213491365,"['FKBP1A', 'JUN', 'STAT1', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'TGFBR1', 'NFKB1', 'MAPK3']",0.9999941002753671,0,0,10
367,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6771094839042715,0.8853818791842061,0.3452301386534562,"['YWHAQ', 'LPL', 'FOXO4', 'PRDM1', 'RAC1', 'NDRG1']",0.9999941002753671,0,0,6
368,GABA receptor Signaling WP4159,0.6861418195722921,0.8779582673005811,0.3307013645539473,"['GABRA1', 'GABRB1', 'GABBR1', 'AP2S1', 'GABRD', 'GABRG3', 'AP2M1']",0.9999941002753671,0,0,7
369,AMP-activated protein kinase (AMPK) signaling WP1403,0.6901903804690118,0.8956931104892989,0.33211208304116374,"['CDKN1A', 'CRTC2', 'PIK3R2', 'ADIPOR1', 'EEF2', 'CPT1B', 'ACACB', 'ACACA', 'GYS2', 'RPTOR', 'GYS1', 'CCNA1', 'CCNB1', 'FASN', 'LEPR']",0.9999941002753671,0,0,15
370,Target Of Rapamycin (TOR) Signaling WP1471,0.6947033473850959,0.8724599391189478,0.31781129858061025,"['RPTOR', 'FKBP1A', 'IDI1', 'RRAGA', 'RRAGC', 'DDIT4', 'AKT1S1', 'RAC1']",0.9999941002753671,0,0,8
371,Wnt signaling WP428,0.7042695000978414,0.8955548824353489,0.3139763327323913,"['PRKCG', 'FZD1', 'JUN', 'CTBP2', 'SERPINF1', 'TCF7', 'NFATC3', 'NFATC2', 'WNT7A', 'CXXC4', 'DKK2', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'ROR1', 'RAC1', 'WNT2', 'PLCB2']",0.9999941002753671,0,0,20
372,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7096081109441428,0.836235708003518,0.28686431908031484,"['RYR1', 'CCKBR', 'CCK']",0.9999941002753671,0,0,3
373,NOTCH1 regulation of endothelial cell calcification WP3413,0.7096081109441428,0.836235708003518,0.28686431908031484,"['JAG1', 'DLL1', 'DLL3']",0.9999941002753671,0,0,3
374,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7096081109441428,0.836235708003518,0.28686431908031484,"['FZD1', 'SFRP4', 'DKK3']",0.9999941002753671,0,0,3
375,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7105803821309321,0.8777322042868484,0.2998975738322207,"['ANGPT2', 'BAD', 'FN1', 'NFKB1', 'NFKBIA', 'STMN1', 'MAPK1', 'BAX', 'NOS1', 'RAC1', 'IKBKG', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9999941002753671,0,0,14
376,Statin inhibition of cholesterol production WP430,0.711228424098983,0.836192487023841,0.2849423141927433,"['ABCG8', 'SQLE', 'LPL', 'APOA1']",0.9999941002753671,0,0,4
377,"Degradation pathway of sphingolipids, including diseases WP4153",0.7139086411608132,0.8362789061813066,0.28182622419109815,"['NEU1', 'GLA']",0.9999941002753671,0,0,2
378,Farnesoid X receptor pathway WP2879,0.7139086411608132,0.8362789061813066,0.28182622419109815,"['SLC10A1', 'FKBP5']",0.9999941002753671,0,0,2
379,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7139086411608132,0.8362789061813066,0.28182622419109815,"['ELOB', 'ELOC']",0.9999941002753671,0,0,2
380,1q21.1 copy number variation syndrome WP4905,0.7151755327494436,0.8361492432242168,0.28030002483216626,"['PYGO1', 'PYGO2', 'ACP6', 'FMO5', 'TJP2']",0.9999941002753671,0,0,5
381,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7151755327494436,0.8361492432242168,0.28030002483216626,"['BDNF', 'FSHR', 'RPS6', 'MAPK1', 'MAPK3']",0.9999941002753671,0,0,5
382,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7151755327494436,0.8361492432242168,0.28030002483216626,"['PRKCG', 'GNA15', 'CACNA1A', 'CA8', 'PLCB2']",0.9999941002753671,0,0,5
383,Sphingolipid pathway WP1422,0.7201524906915535,0.836105976586568,0.27448715139653646,"['PPP2CA', 'CERS4', 'ASAH1', 'GAL3ST1', 'SERINC1', 'GBA2']",0.9999941002753671,0,0,6
384,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7211729843814632,0.8822400832204754,0.2883833278985681,"['PRKCG', 'SHC4', 'PDGFRA', 'MAP2K1', 'PDPK1', 'BAD', 'RPS6', 'GAB1', 'PDGFB', 'NRG1', 'PIK3R2', 'NRG2', 'IGF1R', 'PDGFD', 'MAPK1', 'BAX', 'JAK2', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,19
385,Regulation of Actin Cytoskeleton WP51,0.7236928120252393,0.9013141974552549,0.2914744385159291,"['CHRM2', 'CHRM1', 'CHRM5', 'PDGFB', 'BRK1', 'PIK3R2', 'PIK3C2G', 'FGF1', 'ACTB', 'ACTG1', 'FGF7', 'CFL2', 'TMSB4X', 'CFL1', 'RAC3', 'MAPK1', 'PIP5K1B', 'PIP4K2C', 'RAC1', 'FGF22', 'MAPK3', 'PDGFRA', 'MAP2K1', 'RASSF7', 'FN1', 'ARPC5', 'SSH2', 'FGF17', 'FGF14', 'FGF12', 'FGF10', 'ARHGEF6']",0.9999941002753671,0,0,32
386,G13 Signaling Pathway WP524,0.7312152649677072,0.8360193747247908,0.2617136769460636,"['PPP1CB', 'CFL2', 'CFL1', 'ARHGDIG', 'PIK3R2', 'RAC1', 'CALM1', 'CALM2']",0.9999941002753671,0,0,8
387,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7312152649677072,0.8360193747247908,0.2617136769460636,"['MAP2K1', 'JUN', 'GAB1', 'MAPK1', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,8
388,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7368758042885734,0.8359760394644116,0.25525350993557083,"['IFNAR2', 'CASP8', 'TRAF3', 'STAT1', 'BSG', 'CXCL17', 'FADD', 'NFKB1', 'IFIT2']",0.9999941002753671,0,0,9
389,Codeine and Morphine Metabolism WP1604,0.7386568235400769,0.8363220815752461,0.253340228303093,['ABCB1'],0.9999941002753671,0,0,1
390,Fatty Acid Omega Oxidation WP206,0.7386568235400769,0.8363220815752461,0.253340228303093,['ALDH1A1'],0.9999941002753671,0,0,1
391,FOXP3 in COVID-19 WP5063,0.7386568235400769,0.8363220815752461,0.253340228303093,['IL6ST'],0.9999941002753671,0,0,1
392,Platelet-mediated interactions with vascular and circulating cells WP4462,0.7386568235400769,0.8363220815752461,0.253340228303093,['SELP'],0.9999941002753671,0,0,1
393,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.7386568235400769,0.8363220815752461,0.253340228303093,['RAC1'],0.9999941002753671,0,0,1
394,Role of Osx and miRNAs in tooth development WP3971,0.7386568235400769,0.8363220815752461,0.253340228303093,['NOTCH4'],0.9999941002753671,0,0,1
395,Vitamin B6-dependent and responsive disorders WP4228,0.7386568235400769,0.8363220815752461,0.253340228303093,['PNPO'],0.9999941002753671,0,0,1
396,EGF/EGFR signaling pathway WP437,0.7472594038426513,0.8966875699559613,0.26124355101431107,"['NDUFA13', 'PCNA', 'PEBP1', 'PIK3R2', 'NEDD8', 'FOXO4', 'PLD1', 'ELK1', 'RPS6KA5', 'MAPK7', 'RPS6KA2', 'CFL1', 'STMN1', 'ABL1', 'E2F1', 'AP2S1', 'MAPK1', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'AP2M1', 'VAV3', 'MAP2K1', 'JUN', 'JUND', 'CAV2', 'PDPK1', 'STAT1', 'LIMK2', 'PRKCD', 'GAB1', 'FOS', 'GAB2', 'EPN1', 'VAV2', 'SPRY2', 'FOSB', 'ARF6']",0.9999941002753671,0,0,39
397,Interferon type I signaling pathways WP585,0.7480204044072973,0.835889300193901,0.24267958010391322,"['RPTOR', 'IFNAR2', 'RPS6KA5', 'PRMT1', 'STAT1', 'RPS6', 'RACK1', 'PIK3R2', 'RAC1', 'GAB2', 'EIF4B']",0.9999941002753671,0,0,11
398,Phosphodiesterases in neuronal function WP4222,0.7480204044072973,0.835889300193901,0.24267958010391322,"['ADCY10', 'ADCY9', 'PDE10A', 'ADORA2A', 'PDE4D', 'PPP1R1B', 'PDE3A', 'PDE6C', 'PDE5A', 'NOS1', 'PDE7B']",0.9999941002753671,0,0,11
399,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7480204044072973,0.835889300193901,0.24267958010391322,"['NFKBIA', 'MAP2K1', 'RPS6KA5', 'IRAK1', 'TOLLIP', 'MAPK1', 'MAP3K8', 'FOS', 'ELK1', 'NFKB1', 'MAPK3']",0.9999941002753671,0,0,11
400,IL-1 signaling pathway WP195,0.7534336916357347,0.8358458961474037,0.23663989676779323,"['NFKBIA', 'MAP2K1', 'JUN', 'IRAK1', 'TOLLIP', 'PELI2', 'UBE2N', 'MAPK1', 'PIK3R2', 'IKBKG', 'NFKB1', 'MAPK3']",0.9999941002753671,0,0,12
401,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.755943084887709,0.8524311440677966,0.23850101948012223,"['MAP2K1', 'THRA', 'BAD', 'RPS6', 'DIO1', 'ITPR2', 'SLC16A10', 'TSHR', 'RPTOR', 'CREB3', 'TBC1D4', 'AKT1S1', 'PRKG2', 'MAPK1', 'PRKCQ', 'PPARG', 'HRAS']",0.9999941002753671,0,0,17
402,Differentiation Pathway WP2848,0.7577059989390841,0.7838074181626188,0.21747507517120268,"['NT5E', 'PDGFB', 'FGF1', 'WNT2', 'FGF10']",0.9999941002753671,0,0,5
403,Constitutive Androstane Receptor Pathway WP2875,0.7584112166358439,0.771788781289969,0.21342239534192636,"['PTPA', 'HSP90AA1', 'ABCB1', 'CYP3A5']",0.9999941002753671,0,0,4
404,Hippo-Yap signaling pathway WP4537,0.7584112166358439,0.771788781289969,0.21342239534192636,"['YWHAQ', 'NF2', 'TNIK', 'NDRG1']",0.9999941002753671,0,0,4
405,Purine metabolism and related disorders WP4224,0.7584112166358439,0.771788781289969,0.21342239534192636,"['PRPS1', 'RRM2B', 'PFAS', 'APRT']",0.9999941002753671,0,0,4
406,Triacylglyceride synthesis WP325,0.7584112166358439,0.771788781289969,0.21342239534192636,"['DGAT2', 'MOGAT1', 'LPL', 'AGPAT1']",0.9999941002753671,0,0,4
407,Resistin as a regulator of inflammation WP4481,0.759025107795558,0.792017011104471,0.21837526455990497,"['NFKBIA', 'MAPK1', 'IKBKG', 'PLCB2', 'NFKB1', 'MAPK3']",0.9999941002753671,0,0,6
408,Melatonin metabolism and effects WP3298,0.7614890516536434,0.7979757959948134,0.2174320332112335,"['PER2', 'IRAK1', 'CYP1B1', 'ADRB1', 'CALM1', 'CALM2', 'NFKB1']",0.9999941002753671,0,0,7
409,ESC Pluripotency Pathways WP3931,0.7618527707218218,0.8616994828957836,0.23438394503830323,"['FZD1', 'PDGFRA', 'MAP2K1', 'JUN', 'PDGFB', 'GAB1', 'WNT7A', 'PIK3R2', 'FOS', 'FGF1', 'ELK1', 'FGF17', 'FGF7', 'FGF14', 'MAPK7', 'MAPK1', 'IL6ST', 'WNT2', 'FGF12', 'HRAS', 'FGF22', 'FGF10']",0.9999941002753671,0,0,22
410,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7646282544944606,0.8024940554821665,0.21536172253994626,"['MAP2K1', 'JUN', 'RPS6KA2', 'DDIT3', 'MAPK1', 'FOS', 'JUNB', 'MAPK3']",0.9999941002753671,0,0,8
411,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7646282544944606,0.8024940554821665,0.21536172253994626,"['GABRA1', 'GABRB1', 'SLC12A5', 'BDNF', 'PIK3R2', 'JAK2', 'GABRD', 'GABRG3']",0.9999941002753671,0,0,8
412,Wnt signaling pathway and pluripotency WP399,0.766768854239663,0.8505517071693542,0.22588092031526472,"['PRKCG', 'FZD1', 'JUN', 'PRKCH', 'CTBP2', 'PRKCD', 'TCF7', 'ESRRB', 'WNT7A', 'PPM1J', 'ZBTB33', 'PPP2CA', 'PTPA', 'PPP2CB', 'FRAT1', 'PPP2R1A', 'PRKCQ', 'PRKD1', 'WNT2']",0.9999941002753671,0,0,19
413,PPAR signaling pathway WP3942,0.7719554056055092,0.8088818398096749,0.20936166954260285,"['RXRB', 'FABP5', 'PDPK1', 'FABP6', 'FABP7', 'APOA1', 'ACSL5', 'LPL', 'PPARG', 'CPT1B']",0.9999941002753671,0,0,10
414,Biotin Metabolism (including IEMs) WP5031,0.7760033666733357,0.7167351245430907,0.18176289536608248,"['ACACB', 'ACACA']",0.9999941002753671,0,0,2
415,Cancer immunotherapy by CTLA4 blockade WP4582,0.7760033666733357,0.7167351245430907,0.18176289536608248,"['PPP2CA', 'PIK3R2']",0.9999941002753671,0,0,2
416,Estrogen Receptor Pathway WP2881,0.7760033666733357,0.7167351245430907,0.18176289536608248,"['JUN', 'CYP1B1']",0.9999941002753671,0,0,2
417,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7760033666733357,0.7167351245430907,0.18176289536608248,"['SPARC', 'FN1']",0.9999941002753671,0,0,2
418,Purine metabolism WP4792,0.7760033666733357,0.7167351245430907,0.18176289536608248,"['PRPS1', 'APRT']",0.9999941002753671,0,0,2
419,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7798583839407031,0.8131696891284302,0.2021888980219034,"['UPF1', 'PCNA', 'KAT5', 'CDK5', 'CDKN2A', 'H2AFX', 'ACTL6A', 'E2F1', 'ABL1', 'BAX', 'MCPH1', 'RAD9A']",0.9999941002753671,0,0,12
420,Pathways Regulating Hippo Signaling WP4540,0.7831167108216732,0.8355849889624724,0.20427841866222343,"['PRKCG', 'PDGFRA', 'PRKCH', 'FLT3', 'PRKCD', 'TCF7', 'IGF1R', 'CDH7', 'CDH6', 'PRKD3', 'PRKAR1A', 'CDH20', 'CDH12', 'PRKCQ', 'NF2', 'RAC1', 'PLCB2', 'CDH18']",0.9999941002753671,0,0,18
421,Focal Adhesion WP306,0.7887721570136806,0.8734629057281423,0.20725333413512212,"['SHC4', 'LAMA2', 'LAMA4', 'ITGA2B', 'LAMA3', 'PDGFB', 'PIK3R2', 'ELK1', 'ACTB', 'THBS4', 'MYL12B', 'ACTG1', 'IGF1R', 'PPP1CB', 'PPP1CC', 'PDGFD', 'RAC3', 'TNR', 'MAPK1', 'FLNB', 'RAC1', 'HRAS', 'MAPK3', 'PRKCG', 'VAV3', 'PDGFRA', 'JUN', 'MAP2K1', 'CAV3', 'ITGA4', 'CAV2', 'PDPK1', 'BAD', 'FN1', 'VEGFD', 'VAV2', 'ITGA10', 'ITGA9']",0.9999941002753671,0,0,38
422,Oxidation by Cytochrome P450 WP43,0.7937646650046127,0.7523369421705836,0.17376594946347723,"['CYP39A1', 'CYP26B1', 'CYP1B1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.9999941002753671,0,0,6
423,BDNF-TrkB Signaling WP3676,0.7938480024698177,0.7632008084705666,0.17619503333191208,"['MAP2K1', 'BDNF', 'DLG4', 'GAB1', 'MAPK1', 'GAB2', 'HRAS']",0.9999941002753671,0,0,7
424,MAPK Cascade WP422,0.7938480024698177,0.7632008084705666,0.17619503333191208,"['MAP2K1', 'JUN', 'MAPK1', 'ELK1', 'HRAS', 'LAMTOR3', 'MAPK3']",0.9999941002753671,0,0,7
425,Nephrotic syndrome WP4758,0.794947164929272,0.7715476069505132,0.1770544560872837,"['CUBN', 'ARHGDIA', 'LMNA', 'PMM2', 'COL4A3', 'PDSS2', 'GPC5', 'SYNPO']",0.9999941002753671,0,0,8
426,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7989422455448569,0.7835216759185831,0.17587446170382565,"['FKBP1A', 'JUN', 'STAT1', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'TGFBR1', 'NFKB1', 'MAPK3']",0.9999941002753671,0,0,10
427,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.799373844161757,0.71658560494665,0.16046254414237265,"['B3GALNT1', 'B3GALT1', 'B4GALNT1', 'ST6GALNAC3']",0.9999941002753671,0,0,4
428,Monoamine Transport WP727,0.799373844161757,0.71658560494665,0.16046254414237265,"['PPP2CB', 'TDO2', 'ADORA2A', 'NOS1']",0.9999941002753671,0,0,4
429,NAD+ biosynthetic pathways WP3645,0.799373844161757,0.71658560494665,0.16046254414237265,"['NMNAT1', 'TDO2', 'NADSYN1', 'ACMSD']",0.9999941002753671,0,0,4
430,Vitamin D in inflammatory diseases WP4482,0.799373844161757,0.71658560494665,0.16046254414237265,"['NFKBIA', 'DUSP1', 'IKBKG', 'NFKB1']",0.9999941002753671,0,0,4
431,NAD+ metabolism WP3644,0.8080805148840051,0.6840489325977452,0.145766434773952,"['NT5E', 'NMNAT1', 'NMNAT3']",0.9999941002753671,0,0,3
432,Riboflavin and CoQ disorders WP5037,0.8080805148840051,0.6840489325977452,0.145766434773952,"['SLC52A2', 'RFK', 'PDSS2']",0.9999941002753671,0,0,3
433,SARS coronavirus and innate immunity WP4912,0.8080805148840051,0.6840489325977452,0.145766434773952,"['IFNAR2', 'STAT1', 'TRAF3']",0.9999941002753671,0,0,3
434,G Protein Signaling Pathways WP35,0.8107710011998708,0.8217142509547997,0.17237069496996069,"['PRKCG', 'GNAZ', 'PRKCH', 'PDE4D', 'PRKCD', 'AKAP5', 'GNG13', 'GNG10', 'GNG3', 'GNA15', 'ADCY9', 'PRKD3', 'PRKAR1A', 'GNB2', 'PRKCQ', 'PRKD1', 'PDE7B', 'CALM1', 'HRAS', 'CALM2']",0.9999941002753671,0,0,20
435,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.8131548090396394,0.6271756329113924,0.12972110094488323,['IRAK1'],0.9999941002753671,0,0,1
436,Complement Activation WP545,0.8131548090396394,0.6271756329113924,0.12972110094488323,['C2'],0.9999941002753671,0,0,1
437,Cytokines and Inflammatory Response WP530,0.8131548090396394,0.6271756329113924,0.12972110094488323,['IL7'],0.9999941002753671,0,0,1
438,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.8131548090396394,0.6271756329113924,0.12972110094488323,['ELOVL2'],0.9999941002753671,0,0,1
439,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.8131548090396394,0.6271756329113924,0.12972110094488323,['FN1'],0.9999941002753671,0,0,1
440,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.8131548090396394,0.6271756329113924,0.12972110094488323,['HEY1'],0.9999941002753671,0,0,1
441,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.8131548090396394,0.6271756329113924,0.12972110094488323,['SIX4'],0.9999941002753671,0,0,1
442,Molybdenum cofactor (Moco) biosynthesis WP4507,0.8131548090396394,0.6271756329113924,0.12972110094488323,['MOCS2'],0.9999941002753671,0,0,1
443,Somatic sex determination WP4814,0.8131548090396394,0.6271756329113924,0.12972110094488323,['AMH'],0.9999941002753671,0,0,1
444,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.8131548090396394,0.6271756329113924,0.12972110094488323,['IGF1R'],0.9999941002753671,0,0,1
445,The alternative pathway of fetal androgen synthesis WP4524,0.8131548090396394,0.6271756329113924,0.12972110094488323,['STAR'],0.9999941002753671,0,0,1
446,DNA damage response (only ATM dependent) WP710,0.8143536875843707,0.8223132621951219,0.16887066409369678,"['JUN', 'CDKN1A', 'CDKN1B', 'CDKN2A', 'BAD', 'TCF7', 'WNT7A', 'PIK3R2', 'PIK3C2G', 'SOD2', 'NFKB1', 'BBC3', 'FRAT1', 'CCNG2', 'ABL1', 'RAC3', 'MAPK1', 'BAX', 'RAC1', 'WNT2', 'HRAS']",0.9999941002753671,0,0,21
447,Cysteine and methionine catabolism WP4504,0.8259496585601453,0.6270772883144289,0.11991063044776802,"['AHCY', 'GOT1']",0.9999941002753671,0,0,2
448,Osteoclast Signaling WP12,0.8259496585601453,0.6270772883144289,0.11991063044776802,"['ATP6V1G1', 'PDGFB']",0.9999941002753671,0,0,2
449,TCA cycle in senescence WP5050,0.8259496585601453,0.6270772883144289,0.11991063044776802,"['MDH1', 'GOT1']",0.9999941002753671,0,0,2
450,Signal transduction through IL1R WP4496,0.828089611562171,0.6965710430599554,0.13139691521600522,"['NFKBIA', 'JUN', 'IRAK1', 'TOLLIP', 'NFKB1']",0.9999941002753671,0,0,5
451,22q11.2 copy number variation syndrome WP4657,0.8283337386281471,0.8083752981712166,0.15224870831748674,"['RTN4R', 'PRKN', 'RANBP1', 'RTL10', 'CBX5', 'OAT', 'SERPIND1', 'EMC10', 'RTN4', 'PPP1CB', 'SLC7A4', 'ACTA2', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'CLTCL1', 'DGCR6L', 'RAN', 'FGF10']",0.9999941002753671,0,0,20
452,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8311727538478031,0.8245758468781188,0.15247860231600546,"['SPARC', 'NOTCH4', 'EIF5A2', 'PIK3R2', 'DLL1', 'DLL3', 'CLDN20', 'MAPK1', 'WNT2', 'HRAS', 'MEF2D', 'MAPK3', 'FZD1', 'MAP2K1', 'JAG1', 'FN1', 'WNT7A', 'TGFBR1', 'ZEB1', 'FMNL2', 'MMP15', 'ID2', 'COL4A3', 'PKP2', 'STRAP', 'EZH2']",0.9999941002753671,0,0,26
453,Trans-sulfuration and one-carbon metabolism WP2525,0.8345168800195224,0.6687428521157738,0.12097712566049161,"['AHCY', 'SHMT2', 'DNMT3A', 'MAT2B']",0.9999941002753671,0,0,4
454,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8456979680477135,0.6269788918205804,0.10507727020908549,"['MAP2K1', 'MAPK1', 'MAPK3']",0.9999941002753671,0,0,3
455,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8456979680477135,0.6269788918205804,0.10507727020908549,"['ABCB1', 'RARB', 'PPARG']",0.9999941002753671,0,0,3
456,Overview of interferons-mediated signaling pathway WP4558,0.8456979680477135,0.6269788918205804,0.10507727020908549,"['IFNAR2', 'STAT1', 'JAK2']",0.9999941002753671,0,0,3
457,3q29 copy number variation syndrome WP4906,0.8468881734145547,0.7519439301772018,0.12496301996880056,"['JUN', 'NCBP2', 'DYNLT3', 'UBE2N', 'MAD2L1BP', 'FBXO45', 'SLC51A', 'NF2', 'DYNLRB1', 'DYNLL1', 'DYNLL2', 'PIGX']",0.9999941002753671,0,0,12
458,Hedgehog Signaling Pathway WP4249,0.8483990754453324,0.7019968304278922,0.11541118943974059,"['GRK2', 'EVC', 'HHIP', 'SUFU', 'PTCH1', 'GAS1', 'CDON']",0.9999941002753671,0,0,7
459,Vitamin D-sensitive calcium signaling in depression WP4698,0.8483990754453324,0.7019968304278922,0.11541118943974059,"['G6PD', 'CHRM1', 'CALB1', 'GPX4', 'KCNQ3', 'ITPR2', 'CACNA1C']",0.9999941002753671,0,0,7
460,Autophagy WP4923,0.8514927141707513,0.6837986412847781,0.10993043410001754,"['RPTOR', 'MAP1LC3B', 'ATG101', 'ATG9A', 'AKT1S1', 'WIPI2']",0.9999941002753671,0,0,6
461,Tumor suppressor activity of SMARCB1 WP4204,0.8514927141707513,0.6837986412847781,0.10993043410001754,"['H3F3B', 'CDKN2A', 'PTCH1', 'H3F3A', 'ACTL6A', 'EZH2']",0.9999941002753671,0,0,6
462,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8524455351334569,0.7710637257896988,0.12309720893453975,"['FZD1', 'MAP2K1', 'PDPK1', 'NRG1', 'PIK3R2', 'NFKB1', 'IGF1R', 'MAPK7', 'MAPK1', 'RAC1', 'IKBKG', 'IL6ST', 'CALM1', 'PLCB2', 'CALM2', 'MAPK3']",0.9999941002753671,0,0,16
463,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8643521556402247,0.6268804433887569,0.09138350019114178,"['TICAM2', 'IRAK1', 'IKBKG', 'NFKB1']",0.9999941002753671,0,0,4
464,SARS-CoV-2 mitochondrial interactions WP5038,0.8643521556402247,0.6268804433887569,0.09138350019114178,"['TRAF3', 'PHB', 'PHB2', 'NFKB1']",0.9999941002753671,0,0,4
465,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8653343716345938,0.7335264254520355,0.1060967413304096,"['RPTOR', 'IFNAR2', 'PDGFRA', 'IL15RA', 'DUSP2', 'MAPK7', 'STMN1', 'AKT1S1', 'MAPK1', 'JAK2', 'IL6ST', 'MAPK3']",0.9999941002753671,0,0,12
466,FOXA2 pathway WP5066,0.8656271023662536,0.5573434156921363,0.08042524616054413,"['FASN', 'ACACA']",0.9999941002753671,0,0,2
467,Homologous recombination WP186,0.8656271023662536,0.5573434156921363,0.08042524616054413,"['POLD4', 'POLD2']",0.9999941002753671,0,0,2
468,NO metabolism in cystic fibrosis WP4947,0.8656271023662536,0.5573434156921363,0.08042524616054413,"['PRMT1', 'NOS1']",0.9999941002753671,0,0,2
469,Benzo(a)pyrene metabolism WP696,0.8664204095228192,0.5016877637130802,0.0719345134829537,['CYP1B1'],0.9999941002753671,0,0,1
470,miRNA Biogenesis WP2338,0.8664204095228192,0.5016877637130802,0.0719345134829537,['RAN'],0.9999941002753671,0,0,1
471,Serine Metabolism WP4688,0.8664204095228192,0.5016877637130802,0.0719345134829537,['SHMT2'],0.9999941002753671,0,0,1
472,Vitamin B12 Disorders WP4271,0.8664204095228192,0.5016877637130802,0.0719345134829537,['CUBN'],0.9999941002753671,0,0,1
473,MECP2 and Associated Rett Syndrome WP3584,0.8664289991893019,0.7464543698940956,0.10702297959835985,"['MPP1', 'ARHGEF26', 'GRID1', 'BDNF', 'FOXG1', 'RPS6', 'TAP1', 'POU3F2', 'IGF1R', 'GPRIN1', 'E2F1', 'CDON', 'FKBP5', 'EZH2']",0.9999941002753671,0,0,14
474,Integrated Cancer Pathway WP1971,0.8682757426963613,0.6915136883341685,0.09767350013820483,"['CDKN1A', 'CDKN1B', 'CASP8', 'STAT1', 'BAD', 'E2F1', 'BAX', 'BBC3']",0.9999941002753671,0,0,8
475,Ras signaling WP4223,0.8684015050865517,0.8190626352255376,0.11557064519406782,"['SHC4', 'RAB5B', 'RAB5C', 'FLT3', 'PIK3R2', 'RASAL1', 'FOXO4', 'PLD1', 'ELK1', 'ETS2', 'IGF1R', 'RASGRP3', 'GNG10', 'GNG3', 'ABL1', 'RAC3', 'MAPK1', 'RAC1', 'IKBKG', 'HRAS', 'MAPK3', 'PRKCG', 'PDGFRA', 'MAP2K1', 'BAD', 'GAB1', 'KSR2', 'GAB2', 'NFKB1', 'GNG13', 'GNB2', 'CALM3', 'CALM1', 'CALM2', 'ARF6']",0.9999941002753671,0,0,35
476,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8767293292341042,0.5786888573168256,0.0761305508005982,"['PRXL2B', 'PTGS2', 'PTGES']",0.9999941002753671,0,0,3
477,Kallmann's Syndrome WP5074,0.8767293292341042,0.5786888573168256,0.0761305508005982,"['MAPK1', 'GNRH1', 'PRKCQ']",0.9999941002753671,0,0,3
478,Transcription factor regulation in adipogenesis WP3599,0.8767293292341042,0.5786888573168256,0.0761305508005982,"['CEBPA', 'CEBPB', 'PPARG']",0.9999941002753671,0,0,3
479,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.8767293292341042,0.5786888573168256,0.0761305508005982,"['IFNAR2', 'STAT1', 'TRAF3']",0.9999941002753671,0,0,3
480,Amino Acid metabolism WP3925,0.8829721381497128,0.7423489149726905,0.09239395784235528,"['OAT', 'HIBADH', 'MDH1', 'GOT1', 'MDH2', 'MARS2', 'ODC1', 'GOT2', 'ADH5', 'SRM', 'ACLY', 'LDHA', 'PKM', 'TDO2', 'CPS1', 'ALDH1A1']",0.9999941002753671,0,0,16
481,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8850364136208775,0.6835479531039784,0.08347931190815455,"['IDI1', 'SQLE', 'HMGCS1', 'ELOVL2', 'FASN', 'PMVK', 'MSMO1', 'DHCR24', 'DHCR7']",0.9999941002753671,0,0,9
482,ErbB signaling pathway WP673,0.8856034878771143,0.7554865790159908,0.09178101168540277,"['PRKCG', 'SHC4', 'CDKN1A', 'MAP2K1', 'JUN', 'CDKN1B', 'PDPK1', 'BAD', 'GAB1', 'NRG1', 'PIK3R2', 'NRG2', 'ELK1', 'NRG3', 'ERBB4', 'ABL1', 'MAPK1', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,19
483,Glycerolipids and Glycerophospholipids WP4722,0.8894453077561886,0.5899430239237421,0.0691161083976777,"['DGAT2', 'PCYT2', 'PLD1', 'CDIPT']",0.9999941002753671,0,0,4
484,Sphingolipid Metabolism (general overview) WP4725,0.8894453077561886,0.5899430239237421,0.0691161083976777,"['CERS4', 'ASAH1', 'SMPD1', 'DEGS1']",0.9999941002753671,0,0,4
485,Neural Crest Cell Migration during Development WP4564,0.895252804044076,0.6266833905466068,0.06934197694614024,"['ARF1', 'JUN', 'BDNF', 'RAC1', 'FOS', 'EPHB3']",0.9999941002753671,0,0,6
486,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8968308120101599,0.5015563175943023,0.05461348943153244,"['LDHA', 'SLC2A3']",0.9999941002753671,0,0,2
487,Serotonin and anxiety WP3947,0.8968308120101599,0.5015563175943023,0.05461348943153244,"['GABRA1', 'FOS']",0.9999941002753671,0,0,2
488,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8993082303983755,0.6772831515099557,0.07187968436685321,"['NFKBIA', 'OTUD5', 'CASP8', 'TKFC', 'TRAF3', 'PIN1', 'ISG15', 'IKBKG', 'FADD', 'NFKB1']",0.9999941002753671,0,0,10
489,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.901326467264281,0.6633736475562741,0.06891639445756527,"['ADCY10', 'MAP2K1', 'ADCY9', 'CFL1', 'MAPK1', 'BANF1', 'HRAS', 'EMD', 'MAPK3']",0.9999941002753671,0,0,9
490,Glycerophospholipid Biosynthetic Pathway WP2533,0.9015984768182062,0.5968723286569115,0.06182762042577235,"['PCYT2', 'PTPMT1', 'GPAT3', 'GPAT2', 'CDIPT']",0.9999941002753671,0,0,5
491,Lipid Metabolism Pathway WP3965,0.9015984768182062,0.5968723286569115,0.06182762042577235,"['ACLY', 'PRKAR1A', 'FASN', 'HILPDA', 'ACACA']",0.9999941002753671,0,0,5
492,Regulation of Microtubule Cytoskeleton WP2038,0.9040777996168182,0.6467635402906209,0.06521954535402623,"['SPRED1', 'PARD6A', 'CFL2', 'MAP1B', 'STMN1', 'ABL1', 'TPPP', 'RAC1']",0.9999941002753671,0,0,8
493,Cell Differentiation - Index WP2029,0.9045038346465961,0.41802918424753865,0.04195706026340082,['MEF2D'],0.9999941002753671,0,0,1
494,"Cerebral organic acidurias, including diseases WP4519",0.9045038346465961,0.41802918424753865,0.04195706026340082,['MDH2'],0.9999941002753671,0,0,1
495,Disorders of Folate Metabolism and Transport WP4259,0.9045038346465961,0.41802918424753865,0.04195706026340082,['SHMT2'],0.9999941002753671,0,0,1
496,Disorders of the Krebs cycle WP4236,0.9045038346465961,0.41802918424753865,0.04195706026340082,['DHTKD1'],0.9999941002753671,0,0,1
497,Estrogen metabolism WP697,0.9045038346465961,0.41802918424753865,0.04195706026340082,['CYP1B1'],0.9999941002753671,0,0,1
498,Glial Cell Differentiation WP2276,0.9045038346465961,0.41802918424753865,0.04195706026340082,['TPPP'],0.9999941002753671,0,0,1
499,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.9045038346465961,0.41802918424753865,0.04195706026340082,['STAT1'],0.9999941002753671,0,0,1
500,Ketogenesis and Ketolysis WP4742,0.9045038346465961,0.41802918424753865,0.04195706026340082,['SLC2A1'],0.9999941002753671,0,0,1
501,Methylation Pathways WP704,0.9045038346465961,0.41802918424753865,0.04195706026340082,['MAT2B'],0.9999941002753671,0,0,1
502,Type III interferon signaling WP2113,0.9045038346465961,0.41802918424753865,0.04195706026340082,['STAT1'],0.9999941002753671,0,0,1
503,Insulin Signaling WP481,0.9066869285670465,0.7892112442405151,0.07730960314653391,"['ARF1', 'GSK3A', 'SLC2A1', 'PIK3R2', 'PIK3C2G', 'ELK1', 'IGF1R', 'GYS2', 'GYS1', 'RPS6KA5', 'MAPK7', 'RPS6KA2', 'MAPK1', 'MAP3K8', 'RAC1', 'GYG1', 'HRAS', 'MAPK3', 'CAP1', 'EGR1', 'MAP2K1', 'XBP1', 'JUN', 'PRKCH', 'PDPK1', 'PRKCD', 'GAB1', 'FOS', 'EHD1', 'EHD2', 'PFKL', 'TBC1D4', 'PRKCQ', 'PFKM', 'ARF6']",0.9999941002753671,0,0,35
504,Integrin-mediated Cell Adhesion WP185,0.9085021925522371,0.7271523178807947,0.06977606595654938,"['VAV3', 'MAP2K1', 'CAV3', 'ITGA4', 'CAV2', 'PDPK1', 'ITGA2B', 'PIK3R2', 'VAV2', 'MAPK7', 'CAPNS1', 'ITGA10', 'RAC3', 'MAPK1', 'CAPN1', 'RAC1', 'HRAS', 'ITGA9']",0.9999941002753671,0,0,18
505,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9087174912044435,0.7014448266737232,0.06714301699352603,"['IDI1', 'GSK3A', 'HMGCS1', 'MDH1', 'INSIG2', 'INSIG1', 'LPL', 'ACACA', 'ACLY', 'CDK8', 'SQLE', 'RBP4', 'FASN', 'PPARG']",0.9999941002753671,0,0,14
506,Male infertility WP4673,0.9088437026039117,0.7320859320859321,0.06997434292164653,"['PACRG', 'ABCB1', 'HMGA1', 'PEX10', 'TEX15', 'SOD2', 'CLU', 'ETV5', 'AR', 'CCNA1', 'CYP26B1', 'SPATA17', 'MSH4', 'SIRPA', 'AHRR', 'NOS1', 'HORMAD1', 'TRIP13', 'RAG1']",0.9999941002753671,0,0,19
507,MTHFR deficiency WP4288,0.9103735629386716,0.5571097621770622,0.05231274872198942,"['CHDH', 'DNMT3A', 'EHMT1', 'CYCS']",0.9999941002753671,0,0,4
508,Sphingolipid Metabolism (integrated pathway) WP4726,0.9103735629386716,0.5571097621770622,0.05231274872198942,"['CERS4', 'ASAH1', 'SMPD1', 'DEGS1']",0.9999941002753671,0,0,4
509,Nucleotide Excision Repair WP4753,0.9156317260871617,0.6443521594684385,0.056793870045863455,"['POLE4', 'POLD4', 'PCNA', 'CETN2', 'RPA3', 'POLE2', 'POLD2', 'POLE3', 'RAD23A']",0.9999941002753671,0,0,9
510,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9186435142993465,0.6264861294583883,0.053161819927357766,"['RPTOR', 'MAP1LC3A', 'ATG101', 'AKT1S1', 'WIPI2', 'GTPBP2', 'ACACA', 'FTL']",0.9999941002753671,0,0,8
511,Intraflagellar transport proteins binding to dynein WP4532,0.9191176223837492,0.5696817701833541,0.0480476300329872,"['IFT140', 'DYNLT3', 'DYNLRB1', 'DYNLL1', 'DYNLL2']",0.9999941002753671,0,0,5
512,Chemokine signaling pathway WP3929,0.9208624735563321,0.7418020302074427,0.061157554474985776,"['SHC4', 'VAV3', 'MAP2K1', 'STAT1', 'PRKCD', 'PIK3R2', 'NFKB1', 'CX3CL1', 'GNG13', 'VAV2', 'NFKBIA', 'GNG10', 'GNG3', 'ADCY9', 'GRK2', 'GRK5', 'GNB2', 'MAPK1', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'PLCB2', 'MAPK3']",0.9999941002753671,0,0,24
513,miRNA targets in ECM and membrane receptors WP2911,0.9211669437730667,0.455912328241529,0.03743678289507833,"['LAMA4', 'FN1']",0.9999941002753671,0,0,2
514,Omega-9 FA synthesis WP4724,0.9211669437730667,0.455912328241529,0.03743678289507833,"['ELOVL2', 'FASN']",0.9999941002753671,0,0,2
515,Phytochemical activity on NRF2 transcriptional activation WP3,0.9211669437730667,0.455912328241529,0.03743678289507833,"['CEBPB', 'KEAP1']",0.9999941002753671,0,0,2
516,Transcription co-factors SKI and SKIL protein partners WP4533,0.9211669437730667,0.455912328241529,0.03743678289507833,"['ING2', 'MERTK']",0.9999941002753671,0,0,2
517,TGF-beta Signaling Pathway WP366,0.9214555118598454,0.7450744363562835,0.06094767079535999,"['CDKN1A', 'CITED1', 'NEDD9', 'PIK3R2', 'PARD6A', 'SUMO1', 'MAPK1', 'RAC1', 'JUNB', 'SKP1', 'KLF10', 'MAP2K1', 'JUN', 'JUND', 'LIMK2', 'FN1', 'FOS', 'TGFBR1', 'PJA1', 'EID2', 'KLF6', 'RBL1', 'ZEB1', 'STRAP', 'FOSB']",0.9999941002753671,0,0,25
518,Cannabinoid receptor signaling WP3869,0.9276964401198273,0.5277326332458224,0.039606709685266646,"['ADORA2A', 'PRKAR1A', 'MAPK1', 'MAPK3']",0.9999941002753671,0,0,4
519,Ethanol effects on histone modifications WP3996,0.9276964401198273,0.5277326332458224,0.039606709685266646,"['KAT2B', 'ALDH1A3', 'AHCY', 'ALDH1A1']",0.9999941002753671,0,0,4
520,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9281287212146897,0.626387420718816,0.04671901031884918,"['RPTOR', 'GRIN3A', 'BDNF', 'DLG4', 'MAPK1', 'PIK3R2', 'CACNA1C', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,9
521,Wnt Signaling Pathway WP363,0.9281287212146897,0.626387420718816,0.04671901031884918,"['PRKCG', 'GSK3A', 'FRAT1', 'MAPK1', 'NFATC2', 'PPARG', 'ROR1', 'PIP5K1B', 'RAC1']",0.9999941002753671,0,0,9
522,Mesodermal commitment pathway WP2857,0.9284043274288792,0.7247205124984298,0.053837996430819615,"['VAV3', 'CTBP2', 'ZNF281', 'SLC2A12', 'ELP4', 'ZFHX4', 'DLL1', 'ACACA', 'EXT1', 'PPP2CA', 'CCDC88A', 'ARL4A', 'CSRP2', 'PRKAR1A', 'TRIM5', 'C1QBP', 'BHLHE40', 'RARB', 'RPL38', 'TOX', 'AMH', 'JAK2']",0.9999941002753671,0,0,22
523,15q13.3 copy number variation syndrome WP4942,0.9317316015682228,0.3582730560578662,0.025333662244546366,['KAT2B'],0.9999941002753671,0,0,1
524,ATR Signaling WP3875,0.9317316015682228,0.3582730560578662,0.025333662244546366,['RAD9A'],0.9999941002753671,0,0,1
525,Heme Biosynthesis WP561,0.9317316015682228,0.3582730560578662,0.025333662244546366,['UROD'],0.9999941002753671,0,0,1
526,Iron metabolism in placenta WP2007,0.9317316015682228,0.3582730560578662,0.025333662244546366,['FTH1'],0.9999941002753671,0,0,1
527,Mitochondrial CII Assembly WP4920,0.9317316015682228,0.3582730560578662,0.025333662244546366,['SDHAF1'],0.9999941002753671,0,0,1
528,NLR Proteins WP288,0.9317316015682228,0.3582730560578662,0.025333662244546366,['IKBKG'],0.9999941002753671,0,0,1
529,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.9317316015682228,0.3582730560578662,0.025333662244546366,['NFKB1'],0.9999941002753671,0,0,1
530,Hippo-Merlin Signaling Dysregulation WP4541,0.9370150471034026,0.686573093220339,0.04466565662917714,"['PDGFRA', 'ITGA4', 'FLT3', 'ITGA2B', 'IGF1R', 'CDH7', 'CDH6', 'PPP1CB', 'PPP1CC', 'PRKAR1A', 'CDH20', 'ITGA10', 'CDH12', 'NF2', 'HRAS', 'CDH18', 'ITGA9']",0.9999941002753671,0,0,17
531,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9400145974837419,0.4178756704475512,0.02584973657254451,"['ALOX12', 'LTB4R']",0.9999941002753671,0,0,2
532,Kennedy pathway from sphingolipids WP3933,0.9400145974837419,0.4178756704475512,0.02584973657254451,"['PCYT2', 'ETNK2']",0.9999941002753671,0,0,2
533,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9400145974837419,0.4178756704475512,0.02584973657254451,"['FRAT1', 'MAPK1']",0.9999941002753671,0,0,2
534,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9400377028300373,0.5568758618666197,0.03443458326862228,"['ACTA2', 'ACTC1', 'YWHAQ', 'NF2', 'ACTB', 'ACTG1']",0.9999941002753671,0,0,6
535,Neural Crest Cell Migration in Cancer WP4565,0.9400377028300373,0.5568758618666197,0.03443458326862228,"['ARF1', 'JUN', 'BDNF', 'RAC1', 'FOS', 'EPHB3']",0.9999941002753671,0,0,6
536,Lung fibrosis WP3624,0.9419368567387709,0.5012932172077065,0.029985875280153475,"['FGF7', 'CEBPB', 'PDGFB', 'FGF1']",0.9999941002753671,0,0,4
537,MET in type 1 papillary renal cell carcinoma WP4205,0.943673480113369,0.6261898466419884,0.0363033954212265,"['CDKN1A', 'MAP2K1', 'JUN', 'BAD', 'RPL11', 'GAB1', 'MAPK1', 'PIK3R2', 'RAC1', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,11
538,Phosphoinositides metabolism WP4971,0.9506190619593385,0.5369308536723377,0.027191178435597117,"['PIP4P1', 'PIK3C2G', 'PIP5K1B', 'PIP4K2C', 'PLCH2', 'PLCB2']",0.9999941002753671,0,0,6
539,15q11.2 copy number variation syndrome WP4940,0.9511975184727404,0.3134559599156118,0.01568331207587544,['TUBGCP4'],0.9999941002753671,0,0,1
540,Autosomal recessive Osteopetrosis pathways WP4788,0.9511975184727404,0.3134559599156118,0.01568331207587544,['NFKB1'],0.9999941002753671,0,0,1
541,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.9511975184727404,0.3134559599156118,0.01568331207587544,['TOB1'],0.9999941002753671,0,0,1
542,Serotonin and anxiety-related events WP3944,0.9511975184727404,0.3134559599156118,0.01568331207587544,['FOS'],0.9999941002753671,0,0,1
543,NRF2-ARE regulation WP4357,0.9523438084769713,0.44234052460034146,0.02159911891714234,"['CEBPB', 'KEAP1', 'PGAM5']",0.9999941002753671,0,0,3
544,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9545247667342132,0.38569080616033924,0.017950701479068753,"['HMGCS1', 'FASN']",0.9999941002753671,0,0,2
545,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9545247667342132,0.38569080616033924,0.017950701479068753,"['ACLY', 'MDH1']",0.9999941002753671,0,0,2
546,Fatty acid beta-oxidation WP143,0.956243380256936,0.5011615628299895,0.022423379828762753,"['ECHS1', 'TPI1', 'LPL', 'ACSL5', 'CPT1B']",0.9999941002753671,0,0,5
547,Copper homeostasis WP3286,0.9594860297384364,0.5183613632845578,0.02143814230473062,"['PRNP', 'JUN', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999941002753671,0,0,6
548,Netrin-UNC5B signaling pathway WP4747,0.9594860297384364,0.5183613632845578,0.02143814230473062,"['PTPA', 'MAP2K1', 'JUN', 'MAPK1', 'RAC1', 'MAPK3']",0.9999941002753671,0,0,6
549,Histone Modifications WP2369,0.9628753474117661,0.5313675583089212,0.020102334808836945,"['SET', 'SETBP1', 'H3F3B', 'SUV39H1', 'H3F3A', 'EHMT1', 'EZH2']",0.9999941002753671,0,0,7
550,Nanoparticle-mediated activation of receptor signaling WP2643,0.9630196060573479,0.4556251349600518,0.017168642185237157,"['MAP2K1', 'FN1', 'MAPK1', 'HRAS']",0.9999941002753671,0,0,4
551,Fragile X Syndrome  WP4549,0.9644362454810067,0.6872506474417303,0.02488641113389485,"['CLTC', 'AKAP5', 'RPTOR', 'GRIP1', 'CLTCL1', 'AP2S1', 'MAPK1', 'GABRD', 'AP2M1', 'GABRA1', 'MAP2K1', 'DUSP3', 'BDNF', 'CDKN2A', 'GAB1', 'GRIP2', 'DNM2', 'EEF1A1', 'PRKAR1A', 'DLG4', 'MAP1B', 'AKT1S1', 'CAMK1', 'EIF4G1', 'SHANK1']",0.9999941002753671,0,0,25
552,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.9651138408779192,0.2785982184716362,0.0098928039768579,['NFKB1'],0.9999941002753671,0,0,1
553,Non-homologous end joining WP438,0.9651138408779192,0.2785982184716362,0.0098928039768579,['XRCC6'],0.9999941002753671,0,0,1
554,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.96563832249686,0.3581037796284433,0.012521428909007499,"['PDGFB', 'OMG']",0.9999941002753671,0,0,2
555,Neural Crest Differentiation WP2064,0.9670946219101629,0.5691130175666258,0.019041916784470394,"['CDH6', 'CTBP2', 'PAX7', 'NOTCH4', 'MITF', 'DLL1', 'NFKB1', 'CDH7', 'RHOB', 'DLL3']",0.9999941002753671,0,0,10
556,Integrated breast cancer pathway WP1984,0.9680418617360788,0.6933270219452224,0.022519224957995836,"['GSK3A', 'GDI1', 'ZMYND8', 'ODC1', 'PIK3R2', 'PHB', 'JAKMIP1', 'RASGRP3', 'DHTKD1', 'CASP8', 'ABL1', 'E2F1', 'MAPK1', 'FADD', 'RAC1', 'RPP38', 'PLK3', 'JUN', 'GADD45A', 'STAT1', 'BAD', 'NFKB1', 'TGFBR1', 'FOSL2', 'AR', 'FER', 'BAX', 'FAU']",0.9999941002753671,0,0,28
557,Gastric Cancer Network 2 WP2363,0.9711088591721635,0.39569504235522845,0.011600475460487529,"['OTUD5', 'S100A6', 'CACYBP']",0.9999941002753671,0,0,3
558,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9741122723483511,0.33419502330080014,0.00876550522890492,"['PYGO1', 'FLT3']",0.9999941002753671,0,0,2
559,GPR40 Pathway WP3958,0.9750624145523439,0.2507120253164557,0.0063314301183724706,['PLCB2'],0.9999941002753671,0,0,1
560,Mammalian disorder of sexual development WP4842,0.9750624145523439,0.2507120253164557,0.0063314301183724706,['AMH'],0.9999941002753671,0,0,1
561,Wnt signaling in kidney disease WP4150,0.9776206620167172,0.3758707124010554,0.008507290568815166,"['FZD1', 'WNT7A', 'WNT2']",0.9999941002753671,0,0,3
562,Endoderm differentiation WP2853,0.980256979358416,0.6252981712165385,0.012468769349131461,"['VAV3', 'DUSP4', 'DUSP5', 'DUSP2', 'CTBP2', 'STAT1', 'ZNF281', 'TCF7', 'SLC2A12', 'ELP4', 'ZFHX4', 'ACACA', 'NME1', 'EXT1', 'MAD2L2', 'TRIM5', 'C1QBP', 'TCEAL2', 'TOX', 'EZH2']",0.9999941002753671,0,0,20
563,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9805481193747354,0.3132748615141124,0.0061538329703984375,"['MDH2', 'IDH3B']",0.9999941002753671,0,0,2
564,Canonical and non-canonical TGF-B signaling WP3874,0.9821742844356708,0.22789604909858074,0.004099053954510378,['TGFBR1'],0.9999941002753671,0,0,1
565,Fluoropyrimidine Activity WP1601,0.9827182909633784,0.3579344138710893,0.0062397921846832375,"['RRM2', 'UCK1', 'TYMP']",0.9999941002753671,0,0,3
566,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9854189931922781,0.2948158952317408,0.004330360368594129,"['FLT3', 'DNMT3A']",0.9999941002753671,0,0,2
567,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9870305152482164,0.47681952569667235,0.006224556032077266,"['KIRREL3', 'CDKN1A', 'CDKN1B', 'PCNA', 'JAG1', 'YWHAQ', 'COL4A3', 'SYNPO']",0.9999941002753671,0,0,8
568,Omega-3/Omega-6 FA synthesis WP4723,0.9872581415612011,0.20888273558368495,0.002678656250353447,['ELOVL2'],0.9999941002753671,0,0,1
569,PPAR-alpha pathway WP2878,0.9872581415612011,0.20888273558368495,0.002678656250353447,['APOA1'],0.9999941002753671,0,0,1
570,Splicing factor NOVA regulated synaptic proteins WP4148,0.9884752032654426,0.42922780942321476,0.0049754893988501565,"['CADM3', 'EPB41', 'CAV2', 'APLP2', 'CLSTN1', 'NCDN']",0.9999941002753671,0,0,6
571,Joubert Syndrome WP4656,0.9886300595615404,0.5267333899413967,0.006023234438629944,"['TMEM17', 'KAT5', 'CETN2', 'SUFU', 'BBS9', 'ANKS6', 'ARL2', 'CEP41', 'B9D2', 'ZNF423', 'RAB8A', 'ATF4']",0.9999941002753671,0,0,12
572,Genes controlling nephrogenesis WP4823,0.9890939494452755,0.2784079252029661,0.0030530094719899096,"['PDGFB', 'ETV4']",0.9999941002753671,0,0,2
573,Disruption of postsynaptic signaling by CNV WP4875,0.9911985331715475,0.35776495871507746,0.003162795544281727,"['MAPK1', 'YWHAG', 'MAPK3', 'SHANK1']",0.9999941002753671,0,0,4
574,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9918588486175655,0.2637271099140624,0.0021558297494238716,"['HRAS', 'TGFBR1']",0.9999941002753671,0,0,2
575,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.9934897730379162,0.17900467148884872,0.0011691709657551284,['EZH2'],0.9999941002753671,0,0,1
576,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9934897730379162,0.17900467148884872,0.0011691709657551284,['PECR'],0.9999941002753671,0,0,1
577,Ectoderm Differentiation WP2858,0.9939076873063502,0.5679709900489122,0.003470840362917055,"['BCAS3', 'EDA', 'ELOVL2', 'ARHGDIG', 'SORCS1', 'JAKMIP1', 'CELSR2', 'ZFHX4', 'CDH6', 'SDCBP', 'PLCXD3', 'PPFIBP2', 'PIM1', 'SPRY2', 'NF2', 'CTNNA2', 'MYORG', 'ANKS1B', 'CDON', 'LY6E']",0.9999941002753671,0,0,20
578,mRNA Processing WP411,0.994593353322894,0.587767078176455,0.0031864707641724803,"['SF3B5', 'SF3A1', 'TMED10', 'NCBP2', 'PRMT1', 'CSTF2T', 'SNU13', 'SUPT5H', 'HNRNPAB', 'LSM2', 'PRPF4', 'NUDT21', 'LSM7', 'HNRNPK', 'SNRPD1', 'PCBP2', 'CSTF1', 'CD2BP2', 'SRSF3', 'SNRPE', 'HNRNPH2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.9999941002753671,0,0,24
579,Thermogenesis WP4321,0.9960168239149169,0.5193429816146258,0.00207276538503877,"['RPS6', 'ACTL6A', 'ACSL5', 'CPT1B', 'ACTB', 'ACTG1', 'RPTOR', 'ADCY10', 'CREB3', 'ADCY9', 'RPS6KA2', 'CREB3L2', 'AKT1S1', 'PRKG2', 'PPARG', 'HRAS']",0.9999941002753671,0,0,16
580,Mitochondrial Gene Expression WP391,0.9966735326458238,0.15659612341772153,0.0005217802167115943,['HCFC1'],0.9999941002753671,0,0,1
581,Rett syndrome causing genes WP4312,0.9970276873182462,0.36618212498470376,0.0010900285304317667,"['SRRM3', 'EIF2B2', 'FOXG1', 'IMPDH2', 'GABRD', 'RHOBTB2']",0.9999941002753671,0,0,6
582,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9976220219712164,0.14736907421196327,0.0003508577521432867,['MAP1LC3A'],0.9999941002753671,0,0,1
583,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9976519307538081,0.5313791722823421,0.0012491822503301758,"['CAP1', 'ABCG8', 'MAP2K1', 'GSK3A', 'THRA', 'PDPK1', 'SLC2A1', 'LPL', 'PIK3R2', 'PIK3C2G', 'RPTOR', 'GYS1', 'RPS6KA5', 'MAPK7', 'RPS6KA2', 'FASN', 'MAPK1', 'MAP3K8', 'HRAS', 'MAPK3']",0.9999941002753671,0,0,20
584,DNA Repair Pathways Full Network WP4946,0.9988959945769715,0.499311075781664,0.000551546646736644,"['XRCC6', 'FEN1', 'PCNA', 'CENPX', 'MGMT', 'CETN2', 'H2AFX', 'APEX2', 'RAD23A', 'FANCF', 'POLE4', 'POLD4', 'NEIL2', 'RPA3', 'POLE2', 'APEX1', 'POLD2', 'POLE3', 'USP1']",0.9999941002753671,0,0,19
585,Ciliopathies WP4803,0.9990112297234401,0.5563291915311044,0.0005503539002183311,"['TTC25', 'PKD1L1', 'CCDC28B', 'SUFU', 'NEK1', 'BBS9', 'ZNF423', 'PLK4', 'DNAH11', 'MKKS', 'IFT140', 'SCLT1', 'DCDC2', 'CFAP410', 'TMEM17', 'EVC', 'ARL2BP', 'BBS12', 'MAK', 'ALMS1', 'ANKS6', 'CCDC65', 'CEP41', 'B9D2', 'CCNQ', 'CCDC151', 'KIZ', 'CCNO', 'GAS8']",0.9999941002753671,0,0,29
586,Nanoparticle triggered autophagic cell death WP2509,0.9993780086557789,0.11924854329917621,7.41946383472247e-05,['MAP1LC3A'],0.9999941002753671,0,0,1
587,DNA IR-damage and cellular response via ATR WP4016,0.9995711839434134,0.36271141649048627,0.0001555698371048354,"['UPF1', 'FEN1', 'PCNA', 'H2AFX', 'E2F1', 'USP1', 'IKBKG', 'MCPH1', 'RAD9A']",0.9999941002753671,0,0,9
588,Pathways affected in adenoid cystic carcinoma WP3651,0.9998271614507812,0.2603891675466385,4.500917572342312e-05,"['MORF4L1', 'CEBPA', 'CNTN6', 'MAGI2', 'HRAS']",0.9999941002753671,0,0,5
589,Energy Metabolism WP1541,0.9998813107953417,0.1923685812867871,2.283342898174253e-05,"['PRMT1', 'PPARG', 'MEF2D']",0.9999941002753671,0,0,3
590,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999941002753671,0.2768819572943284,1.6335321225657568e-06,"['MKKS', 'TMEM17', 'EVC', 'IFT140', 'BBS12', 'CDK20', 'SCLT1', 'BBS9', 'TULP3', 'DYNLL1']",0.9999941002753671,0,0,10
